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SUMMARY 
A study was performed to detect the viral conjunctivitis in HUSM caused by HSV using 
a PCR method. Seventy patients with viral conjunctivitis were examined; with clinical 
features identified and conjunctival scrapping taken frmn superior and inferior fornices of 
affected eye for PCR analysis. PCR was perfom1ed with primers obtained from a 
I l 
commercially available primer kit for HSV. The prevalence of viral conjunctivitis in 
HUSM cau~ed by HSV infection, using PCR method, was 17 .I % (95 % CI = 8.1, 26.0) 
which was higher than other reported studies. This is mainly dtie to the method used 
I 
which is a highly sensitive and specific diagnostic test. Majority of HSV conjunctivitis 
patients presented with moderate follicular conjunctivitis with frequent corneal 
involven1ent which was silnilar to features of adenoviral conjunctivitis caused by Group 
0 subgenera. The possible differentiating feature fron1 adenoviral conjunctivitis was the 
uniJateraJity. 
Key war is : Viral conjunctivitis ; Polytnerase Chain Reaction ; Herpes Simplex Virus ; 
Conjunctival Scrapping 
----------· ··---G 
INTRODUCTION 
Conjunctivitis and keratitis are common ocular morbidity seen in general practice and eye 
units. The most common cause of these diseases is microbial infection which can either 
be viral, bacterial or parasitic infection. 
Viral conjunctivitis in East Asia including Japan, Korea and Tai,van is caused 
I I 
mainly by Adenovirus and has gained recognition as a n1ajor international public health 
problem in these regions.' In Japan, adenoviruses are the tnost prevalent causative agent 
of viral conjunctivitis and! were isolated from 91.2% of cases of clinically diagnosdd EKC 
in which the aetiological agent was determined virologically, followed by Herpes 
Simplex virus (HSV) in 4.3% and Chlamydia trachomatis in 2.5% of cases.2 Herpesvirus 
infection is frequently diagnosed in dendritic or geographic corneal ulcers, disciform 
keratitis, and keratouveitis and very rarely itnplicated as a cause of conjunctivitis alone 
\vithout corneal or lid lesions. However, there have been only fe\v papers describing the 
epidetniological features of HSV conjunctivitis. 3•4 
Accurate labor2 tory investigations for HSV is often valuable due to tl e limited 
reliability of clinical ( iagnosis of HSV induced keratoconjunctivitis. The p )tentially 
serious residual n1orbidLty of these infections and availability of appropriate trec.ttnent for 
I 
I 1 
HSV further justify the need for detection of this virus in cases of keratoconjtlnctivitis 
There probletns in diagnosing HSV conjunctivitis includes uncon11non presentation 
which are clinically indistinguishable from other more likely causes such as adenoviruses 
and difficulty in isolation of this virus using viral culture as it requires sensitive cells for 
culture isolation, viable organistns necessitating special transport media and pron1pt 
---- . ------··--
' ...... -':-
transport of specimens from patient to laboratory, as well as it is costly and time 
consuming. 
Polymerase chain reaction (PCR) has been shown to be of valuable technique and 
offers great advantage compared to conventional method in the diagnosis of viral 
infections in view of its sensitivity and speed as well as and the need of small san1ple 
I 
volume. Thus, it is one of the diagnostic method used for the diagnosis of herpesviruses. 
5,6,7 
Due to the serious tnorbidity of this infection, we conducted a study to detect 
I 
HSV infection in viral conjunctivitis and consequently, determine the prevalence rate of 
I 
the infection in viral conjunctivitis cases in Hospital University Sains Malaysia. In 
addition, we would also like to identify the clinical features pertaining to HSV 
conjunctivitis which tnight help us in differentiating it fron1 other causes of viral 
conjunctivitis and hence, assist us in diagnosing and tnanaging these cases. 
..---.. --------·---- ~~-----------------
MATERIALS AND METHODS 
This study is a cross sectional study in which approval was obtained from the Research 
and Ethical Committee, School of Medical Science, University Sains Malaysia. 
Clinical Examination 
All cases of conjunctivitis were screened at the Ophthalmology and Outpatient Clinics, 
HUSM between November 2002 to November 2003 by one ophthalmic officer. A clinical 
history was taken and patients were examined with slitiJmp. Attention was paid to the 
signs in the tarsal and bulbar conjunctivae, fornices and ~ids. The cornea was examined 
and stained with fluorescein to detect any epithelial abnonnality. Clinical features of the 
viral conjunctivitis cases were then documented. Based on these, seventy patients were 
identified to have clinically diagnosed viral conjunctivitis and had consented to be 
included in this study. Patients were of either sex who \vere 7 years or older so as to be 
able to give infonnation regarding sytnptmns. Cases of clinically diagnosed pritnary 
1nicrobial conjunctivitis or non-infective conjunctiviti~ were excluded from the study. 
Patients started on systemic or topical antiviral treat1nen were also excluded. 
I 
, Clinical Satnpling 
Conjunctival swab was obtained by scrapping the superior amd inferior fornices with a 
sterile swab. Specimen was placed in a viral transport tnedium ( Hanks Balanced Salt 
Solution ), stored in the freezer at 4oc and transferred to the laboratory on the san1e day 
in an ice box. In the laboratory, the specimen was stored at - 40°C until processed for 
PCR. 
-------~~----·--
Polymerase Chain Reaction 
For detection of herpes simplex virus DNA by PCR, DNA from samples were extracted 
using Nucleospin Kit ( Clontech, USA ). The an1ount of DNA in the samples was 
determined using a spectrophotometer ( Eppendorf Photometer ). PCR was carried out 
' I 
using Herpes Simplex Virus Type 1/2, DNA polymerase, Primer set kit (Cat. No.: SP-
I 03 I 9, Maxim Biotech. Inc.), according to the manufacturer's recommendation. 
The !master mixture was prepared by adding 250 Jll of pre-mixed primer, 
I 
provided by HS\T Type I/2, DNA polymerase, pritner set kit (Sequences: Alignment on 
I 
database;- HSIDP & HS2POL, X04771, MI6321 ) to each 750 J.Ll tube of optimized 
PCR buffer ( 2 mM MgCI2, I 5 1nM Tris-HCL, 30 111M KCI, 0.25 J.LM dNTPs Mix, 
enhancer & stabilizer- con1ponent of HSV Type 1/2 , DNA polyn1erase, primer set kit). 
The PCR assay was perforn1ed under the following conditions : To 20 ~tl of Master 
Mixture, 0.1 ~d of Taq DNA polytnerase and 5 J..ll of speci1nen or control eDNA were 
added. The fin tl volume was made up to 25 J..tl with distilled water. Po: .itive and negative 
controls were ncluded for every set of PCRs as tneasures to avoid c >ntatnination. The 
positive contrc I consisted of a clone containing PCR fragn1ent \vhich was PCR product 
I I . 
derived fron1 1-ISV Type I genomic DNA using HSV- 1012 N/ 1013 N as the prin1ers 
whereas the negative control consisted of deionised sterile water ( both \Vere con1ponents 
of HSV Type 1/2 , DNA poly1nerase, pritner set kit ) . PCR \Vas carried out using 
Eppendorf Mastercycler Gradient with the following temperatures : initial denaturation at 
96°C for I tninute, followed by 35 cycles of DNA denaturation at 94°C for I minute, 
pritner annealing at 58°C for I minute and pritner extension at 72°C for I minute. For the 
------·-----·-----
last cycle of PCR, the 72°C step was extended to 10 minutes. Ten microliters of PCR 
products were subjected to electrophoresis on 1.2% agarose containing ethidium bromide 
and were then examined under ultraviolet light. 
Statistical Analysis 
Data entry and analysis were· done using SPSS version I 0. All patients' data were 
analysed by descriptive analysis. 
(· _______ __,_--. --·---- G 
RESULTS 
Out of 70 patients clinically diagnosed as having viral conjunctivitis, 12 ( 17.1%) patients 
were positive for herpes simplex virus (HSV) by PCR method ( Table I ). Thus, in this 
study, the prevalence of herpes simplex infection in viral conjunctivitis in HUSM was 
found to be 17.1 % (95% CI = 8.1, 26.0). 
\ 
I I 
In our study, the mean age of patients having HSV conjunctivitis was 35.15 years 
± 14.98 and it occured most frequently between 21 to 40 year age group that was 58.3% 
I ( Table II ) . There was slight female preponderance in cases of HSV conjunctivitis which 
accounted for 7 ( 58.3 %) females and 5 ( 41.7 % ) males. The majority of the HSV 
I 
conjunctivitis cases comprised ofMalays (91.7 %), followed by 8.3% of Chinese. 
Contact conjunctivitis \Vas noted to be the major source of infection for HSV 
conjunctivitis in this study, accounting for 66.7 % ( 8 out of 12 cases). The remaining 4 
(33 .3%) patients had not been aware of contact with conjunctivitis, respiratory infection 
(URTI ) or urogenital disease. Out of 12 p 1tients of HSV conjunctivitis, 7 (58.3%) had 
been in close contact with a fatnily n1etnb !r suffering from conjunctivitis. One patient 
gave history of exposure to another patient }· aving conjunctivitis. 
All HSV conjunctivitis patients presented with foreign body sensation and 
! I 
Iacritnation. Other syn1ptoms included e)re discharge (9 cases), itchiness (9 cases) 
photophobia (7 cases) and blurring of vision (6 cases). Majority of HSV conjunctivitis 
cases were found to be unilateral (9 out of 12 cases; 75.0%). Moderate conjunctivitis vvas 
found in 6 patients (50%) whereas mild and severe conjunctivitis were seen in the 
retnaining ones accounting for 3 cases (25%) each. The conjunctival reaction in HSV 
conjunctivitis was n1ainly of follicular response which was 50.0% (6 out of 12 cases). 
Corneal involvement occurred in 7 (58.3 %) out of 12 patients with HSV conjunctivitis 
which were mainly of punctate type. One case presented with dendritic keratitis and 
another with disciform keratitis. Pseudomembrane and preauricular lymphadenopathy 
was elicited in 3 cases (25%) and I case(8.3%) of HSV conjunctivitis, respectively. No 
herpetic vesicles at lids were seen in patients with HSV conjunctivitis. 
----. -----. ------t'r--- ----~----------~ 
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Table I : Result of PCR test to detect herpes simplex virus in viral conjunctivitis 
PCR test No of patients (n=70) Percentage(%) 
Positive for HSV 12 
Negative for HSV 58 82.9 
, I 
'' 
Table II : Distribution of HSV conjunctivitis according to age 
Range of age (year) No of patients (n=l2) Percentage(%) 
7 to 20 2 16.7 
21 to 40 7 58.3 
41 to 60 2 16.7 
61 to 80 8.3 
~-·--·.,··-··-····-··-----~ --~······.--<·-~-
DISCUSSION 
Viral conjunctivitis is a common eye problem encountered not only in ophthalmology 
clinic but in outpatient clinic as well. Various viral aetiologies have been incriminated 
causing it, including adenovirus, vaccinia, herpes simplex virus and poxvirus, with 
adenovirus being the most prevalent causative agent. 
l 
In this study, the method used was polymerase chain reaction alone. Ideally, there 
should b~ ~comparison with the present gold standard which is viral culture. There are 
few reasons why this method had been chosen for tpis study. Firstly, polymerase chain 
reaction is a more sensitive and specific method cotnpared to viral culture tnethod. This 
fact has been established in many studies conducted throughout the world. 5•6•7 The high 
sensitivity and specificity of PCR in detecting HSV may help us to start antiviral 
treattnent such as acyclovir earlier, and thus, tnay avoid possible serious cotnplication 
such as keratitis \vhich can lead to corneal perforation and blindness. 
The use of viral culture as a gold standard is not practical in this study. Mainly, it 
was due to the budget constraint as this tnethod is c uite expensive. Secondly, even though 
viral culture remains the gold standard for definiti' e isolation and further characterization 
of the organism, the pitfalls of this rnethod are nu nerous. Viral isolation requires viable 
organisms and hence, special transport media as well as prompt transport of specin1ens 
from patient to laboratory is necessary 8 and this is difficult to be applied in our clinic 
setup due to the lack of n1an power. Thirdly, it is titne consuming, insensitive and 
subjective, along with requiretnent of highly technically trained personnel. 
In our study, it was found that the prevalence rate of herpes simplex infection in 
viral conjunctivis in HUSM was 17.1 o/o ( 95o/o CI =8.1 ,26.0). However, this is not in 
·--~--~----· .... -----
accordance with previous reports in which the prevalence of HSV ocular infection ranges 
from 1.4 to 7%. 2•3•9 The higher prevalence of HSV conjunctivitis in our study might be 
due to few reasons. First, the prevalence in previous reports of HSV conjunctivitis were 
referring only to cases with acute follicular conjunctivitis in the absence of corneal or lid 
signs whereas our study was referring to cases of HSV conjunctivitis which either 
presented '~ith conjunctivitis alone, blepharoconjunctivitis or \keratoconjunctivitis. 
Therefore, the pick-up rate ofHSV infection was more compared to the reported studies. 
Furthennore, in our study, the method used in detecting the prevalence of herpes 
I I 
sitnplex ocular infection was by PCR method which is very sensitive: and highly specific 
I I 
as compared to viral culture which was the tnethod used in previous studies in detecting 
the prevalence of herpes simplex ocular infections. Another explanation that may 
contribute to the high prevalence rate of HSV conjunctivitis in this study is the fact it \vas 
a hospital based study as compared to other studies n1entioned, which \vere 
epiden1iological studies. The results found \Vere actually cotnparable to one hospital 
based stud·' done by Wishart et al (1994) showing that 21% of acu ~e conjunctivitis cases 
found in or •hthalmic casualty department were due to HSV infectiOJ .1? 
In ~ .ddition, the small sample size obtained may contribute · o the high prevalence 
rate of HSIV conjunctivitis in HUSM. As a result, it tnay give rise: to a seen1ingly high 
I I 
epidetniological frequency. 
This study has shown that the age of the patients with HSV conjunctivitis ranged 
frmn 12 to 68 years but the conjunctivitis is more commonly seen among adult age group 
(21 to 40 years old) accounting for 58.3 o/o of cases. This result is slightly different from 
the study done by Uchio et al (2000) whereby tnost of the cases occurred in 50-59 year 
---·---- r; 
age group. It may be due to the age distribution in these two different places. Kelantan 
population has 41.5% of total population below 15 years of age whereas Japanese 
population has a larger size of older population. 11 
In this study, it was impossible to determine whether the infection was primary or 
recurrent since we did not measure serum antibody level to HSV. However, it has been 
I I 
reported that the reliability of serological tests for the diagnosis of HSV infection is 
limited! 2•13 Our result, therefore suggest that there is no significance difference in the 
clinical features of HSV conjunctivitis. 
I 
Several studies had shown that there was no sex difference in primary HSV ocular 
infection. 9•14 • However, in ~ecurrent HSV ocular infection, studies by Wilhelmus et al 
( 1981) and Wishart et al ( 1987) demonstrated that incidence was higher in tnale 
cotnpared to fetnale aged over 25 and 15, respectively. 15• 16· 
Our study has sho\vn that there is fen1ale preponderance In cases of HSV 
conjunctivitis accounting for 58.3% fetnales and 41.7o/o n1ales but in tenn of cases, the 
distribution is almost equa where 7 cases are fetnales and 5 cases were 1nales. A; this 
study consists of both prin ary and recurrent HSV ocular infections, the result obt 1ined 
cannot be compared with. other series and hence, sex difference cannot be eli ~ited. 
I 
However this is not signi~cant considering sample size was very small and thus, not 
reflecting the true picture. 
Based on ethnic group, majority of HSV conjunctivitis cases 1n this study 
comprised of Malay, again reflecting the racial distribution in Kelantan population. 11 
Apart from that, there was no significance of this observation given the small number of 
cases involved. 
o; ...... ····----·-------.,...--·----
With regards to the source of infection in this study, the major source of infection 
for HSV conjunctivitis was contact conjunctivitis in which 7 had been in close contact 
with family members and one contracted it from other patients. This finding is similar to 
i 
the pattern seen in the study of HSV conjunctivitis by Uchio et al (2000), the largest 
proportion of patients had been in close contact with a friend or colleague suffering fron1 
. . •. 2 COnJUnCtiVItiS. 
H!Jm_ans are the sole natural hosts of HSV. The virus can be transmitted by direct 
contact with infected cutaneous lesions, secretions of infected mucosa, salivary droplets 
I 
from children and adults with active disease (cold sores), and the saliva or fmnites of 
asymptomatic, virus-shedding carriers. 1? A st~dy by Darougar et al, demonstrated that the 
source of infection identified in 24% of cases \Vere contact with patients with an active 
skin HSV infection or patients having HSV lesions on their own lips, nose or face. 9 
Spread via droplets is postulated, but not \veil docun1ented. 18 These various sources of 
infection could probably be elicited in our study with a larger san1ple size. 
Regarding the clinical presentatio 1 of HSV conjunctivitis in our study, the 
symptoms were tnainly of eye irritatior described as foreign body sensation and 
lacrimation, as well as tnucoid eye discharg ~, followed by photophobia and blurred vision 
; 
which were less frequent. Majority of ~SV conjunctivitis patients showed n1oderate 
donjunctivitis which accounted for 50% of cases with the conjunctival reaction seen was 
1nainly of follicular type. This finding corresponds well to the fact that one of the n1ain 
causes for follicular reaction is viral infection. 19 
As for keratitis associated with conjunctivitis in this study, generally the con1eal 
involvement was seen frequently in the HSV conjunctivitis, con1monly of subepithelial 
... ~-·-. ~ 
punctuate type. Apart from that, it was noted in our study that all four cases of HSV 
conjunctivitis treated by topical antibiotic with steroid showed corneal involvement (3 
cases of punctate keratitis and a case of dendritic ulcer). Nevertheless, these findings 
could not really differentiate whether the corneal involvement was due to the treatment or 
they were just part of the natural course of HSV ocular infection. 
\ i 
Topical steroid can be associated with punctate keratitis which may be attributed 
to the preservatives, or the mechanical effects of aggregates of steroid particles in 
suspdnsion producing a mechanical epithelial keratitis.20 The use of topical steroid has 
I I 
been associated with prolongation of infectious epithelial ulceration and with an increase 
I I 
in the size of these ulcers. Progression from dendritic to geographical ulceration and, 
probably, the risk of developing strotnal inflammation later, are enhanced by the use of 
steroids, particularly when used during the stage of active viral replication in the 
. 1 I. 21 eptt 1e tum. 
Though, looking at our study the corneal involven1ent in HSV conjunctivitis 
oc ;urred quite fi·equently (58.3%), we are still unable to :.ay whether it is a part of the 
na. :ural course of disease or as a complication of steroid therapy as this was a cross-
se;;tional study. 
I 
Herpes simplex virus should always be considered ;in the differential diagnosis of 
acute or subacute follicular conjunctivitis. 18 Acute follicular conjunctivitis in HSV ocular 
infection can occur in both prirnary and recurrent HSV ocular infection, with or without 
lid or corneal involvement.9' 16 Parallel to these observations, most of the patients with 
HSV conjunctivitis in this study presented with acute follicular conjunctivitis. 
..... -·-----~ ........... -.....---~-,..-~--· 
The clinical features seen in our study was similar to the ones seen in adenoviral 
conjunctivitis type 8 and 19 from group D subgenera which consisted of moderate to 
severe conjunctivitis with commonly subepithelial punctate lesion.22 The degree of 
I 
moderate to severe follicular conjunctivitis of HSV infection with ' less frequent 
preauricular lympadenopathy were also comparable to the study done by Uchio et al 
(2000) but their s1t~dy noted that early corneal lesions was less frequent?\ These mixed 
and dissimilar findings may be due to the small sample size of our study in comparison 
with other publisheq studies. 
I 
In this study, it had shown that 75% ofHSV conjunctivitis patients presented with 
I j 
unilateral involvement. This is consistent with several studies indicating that HSV ocular 
infection is unilateral in majority of cases (about 80% to 90%) whereas bilateral disease 
is unusual and occurs in about 2% of patients in separate studies.2' 15'23 Although the lo\v 
occunence of bilateral illness tnay help to discriminate HSV conjunctivitis fron1 
adenoviral conjunctivitis, it seems difficult to differentiate then1 clinical~y, especially in 
the early clinical : .tage. 
Currently diagnosis of infectious disease is can-ied out by routt 1e n1icroscopy, 
culture and serol~~gical methods, which takes around 1-3 days and even ~~.to 2 weeks io 
a 1nonth. For seri~us life threatening and vision threatening, infections an~ pathogens that 
i 
are difficult to culture, immediate diagnosis will have a great impact in appropriate 
treatment and proper clinical tnanagement. This is rightly so in cases of HSV ocular 
infections. In addition to the availability of treattnent which are used not only to treat but 
preventing complications, the higher prevalence rate of HSV conjunctivitis in this study 
may warrant the need for diagnostic testing. 
('i 
In this genomic era with the availability of microbial genome sequences it is 
possible to carry out molecular DNA based diagnostic tests for almost all infections and 
this includes HSV infections. Having said that, although this prevalence study was not 
validated by comparison against an established gold standard which is the viral culture 
but in ideal situation, the use of PCR as a diagnostic test might be very useful. 
I I I 
Polymerase chain reactioti (PCR) has been a proven model for rapid diagnosis.; 
Apart from having higher sensitivity compared to conventional methods, the other 
potential advantages are the same/ day diagnosis (2 to 4 hours result) as well as the same l 
day identification of pathogen. Nonetheless, due to its sensitivity, false positive result 
j 
may be found as a result of contamination of samples and this can be avoided by · 
tneticulous use of preventive measures. The specificity of primers is typically analyzed 
by evaluating the production of the target fragment in relation to other products by gel 
electrophoresis. In our study, we had used a con1mercially available prin1er kit which is 
Herpes Si1nplex Virus Type 1/2, DNA polymerase, Primer set kit (Cat. No.: SP-1 0319, 
Maxim Biotech. Inc.). 
Furthermore, no\vadays, the PCR test is becoming less expensive than before. TJ e 
expenditure of a laboratory ~etup for PCR is actually tnore or less siinilar to oth !r 
laboratory set up, particularly /the viral laboratory, ranging around RM 300 000 to Rfv! 
350 000 and thus, the application of PCR as a diagnostic test n1ay actually be cost 
effective. 
Once again, owing to its high sensitivity and specificity as well as other protnising 
advantages, the PCR may one day be the 'gold standard' of diagnostic test in replacetnent 
of the conventional method, with special regard to viral isolation which obviously has a 
"* .. ......,....._.....,_....---...------~---
,_:,.:· 
low sensitivity and lots of drawbacks. In fact,JPCR amplification of HSV DNA in CSF 
specimens is now the recognized reference standard assay for the sensitive and specific 
diagnosis of central nervous system infections caused by HSV.24 
i \ I , 
I 
I 
! I i : 
-----L'i- ---···--· 
CONCLUSION. 
This study showed the prevalence of viral conjunctivitis caused by herpes simplex 
infection, in HUSM was higher than other reported studies. This could be due to the 
method used which was PCR method; as well as the type of study carried out which was 
a hospital based study as compared to other studies with lower prevalence rate of HSV 
·' \ I 
conjunctivitis which were of epidemiological based studies. 
One-- of the limitations in this study is a lack of comparison with other method 
such as tiral culture which remains "the gold standard" at present. It could not be done in 
this study due to the time and budget constraints. In tern1s of clinical features, 
i 
unilaterality with presence of 1noderate follicular conjunctivitis are highly suggestive of 
HSV conjunctivitis and may help to distinguished it fron1 adenoviral conjunctivitis. Even 
though certain results are cotnparable to other studies but their significance could not be 
elicited due to a sn1all sample size \Vhich was another litniting factor. This probletn is 
also a;')plied in analyzing the detnographic characteristics of H~V conjunctivitis. 
Finally, we recommend further study with larger sampl! size needed to detennine 
the tn: e 'prevalence of HSV conjunctivitis and its clinical feat .tres as well as to identify 
the demographic pattern which tnay contribute as risk factors for HSV conjunctivitis. 
I : 
I I i I 
This sttidy should be done ·with comparison \vith the current gold standard that is the viral 
I ' 
culture and preferably, multicentered, especially if time is the tnajor constraint in getting 
a larger sample size. This study should also be a prospective type as information 
regarding the natural course of the disease can then be obtained and hence developing 
strategies to bring the disease under control, along with preventing complications. 
.. ··- -- .. ~-__ .,... __ -~·-....... ~ _.,.._...__~.-·..,..,_. -~-. ~- _'!'fr-
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ABSTRAK 
Objektif : Untuk mengesan kes-kes konjunktivitis virus yang disebabkan oleh virus 
herpes simplex di Hospital Universiti Sains Malaysia, dengan menggunakan teknik 
'polymerase chain reaction'. 
Bentuk Kajian: Kajian berasaskan hospital secara 'kajian rentang'. 
Kaedah Kajian : Kajian dijalankan di klinik mata, HUSM selama 1 tahun di mana 
seramai 70 pesakit telah dikaji. Gejala-gejala pesakit yang mengidapi konjunktivitis virus 
telah dikenalpasti dan kikisan pada lapisan konjunktiva dilakukan pada fornix sebelah 
atas dan sebelah bawah mata yang bermasalah, dengan menggunakan swab yang steril. 
Analisa PCR telah dilakukan pada kikisan konjunktiva tersebut. Kaedah PCR dijalankan 
dengan menggunakan primer untuk HSV yang didapati dari kit yang dipasarkan secara 
komersial. Kehadiran sasaran produk amplifikasi ditentukan oleh gel agarose. Ini 
menandakan samada konjunktivitis virus adalah disebabkan oleh jangkitan HSV atau 
tidak, seterusnya menunjukkan prevalens konjunktivitis virus yang disebabkan oleh 
jangkitan HSV. Data di dalam kajian ini dianalisakan mengikut analisa deskriptif perisian 
SPSS. 
Keputusan : Kadar prevalens bagi kes-kes konjunktivitis virus di HUSM, yang 
disebabkan oleh virus herpes simplex, dengan menggunakan kaedah PCR, adalah 17.1% 
(95% CI = 8.1, 26.0). Majoriti dari pesakit yang menghidapi konjunktivitis virus herpes 
simplex mengalami konjunktivitis yang sederhana dan kebanyakan kes-kes tersebut 
XI 
melibatkan keradangan pada kornea. Selain daripada itu, sebahagian besar dari pesakit-
pesakit ini juga menunjukkan penglibatan konjunktivitis secara unilateral. 
Kesimpulan: Kajian menunjukkan kadar prevalens konjunktivitis virus yang disebabkan 
oleh jangkitan herpes simplex di HUSM adalah Iebih tinggi jika dibandingkan dengan 
kajian-kajian sebelum ini. Salah satu daripada sebabnya ialah kaedah PCR yang lebih 
sensitif dan spesifik. Sebahagian daripada gejala-gejala konjunktivitis HSV didapati 
hampir sama dengan gejala-gejala konjuktivitis adenovirus daripada kumpulan D 
subgenera. Hanya ada satu gejala yang mungkin dapat membezakan konjunktivitis HSV 
daripada konjunktivitis adenovirus iaitu dari aspek penglibatan secara unilateral. 
xu 
ABSTRACT 
Objective : To detect the viral conjunctivitis in Hospital Universiti Sains Malaysia 
caused by herpes simplex virus using a polymerase chain reaction method. 
Design: A cross sectional hospital-based study. 
Method : A total number of 70 patients with viral conjunctivitis were seen in the 
ophthalmology clinic, HUSM during one year period. The presenting clinical features 
were identified and conjunctival scrapping using sterile conjunctival swab was taken 
from superior and inferior fornices of the affected eye for PCR analysis. The PCR was 
performed with primers obtained from a commercially available primer kit for HSV. The 
presence of this amplified target sequence was determined by agarose gel. A positive 
result reflected the prevalence of viral conjunctivitis caused by HSV. Descriptive analysis 
was performed using SPSS system. 
Results : The prevalence of viral conjunctivitis in HUSM caused by herpes simplex 
infection, using PCR method, was found to be 17.1% (95% CI = 8.1, 26.0). Majority of 
HSV conjunctivitis patients presented with moderate follicular conjunctivitis with 
frequent corneal involvement, commonly subepithelial punctuate keratitis. It was also 
observed that a larger portion of HSV conjunctivitis patients presented with unilateral 
involvement. 
xiii 
Conclusion : This study showed the prevalence of viral conjunctivitis caused by herpes 
simplex infection, in HUSM was higher than other reported studies. The most important 
cause for high prevalence is the PCR method used which is a highly sensitive and 
specific diagnostic test. Some of the clinical features ofHSV conjunctivitis was similar to 
adenoviral conjunctivitis caused by Group D subgenera. The only possible differentiating 
feature was the unilaterality which may help to discriminate HSV conjunctivitis from 
adenoviral conjunctivitis. 
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1. INTRODUCTION 
1. INIRODUCTION 
Conjunctivitis and keratitis are common ocular morbidity seen in general practice and eye 
units. The most common cause of these diseases is microbial infection which can either 
be viral, bacterial or parasitic infection. 
Viral conjunctivitis in East Asia including Japan, Korea and Taiwan is caused mainly by 
Adenovirus and has gained recognition as a major international public health problem in 
these regions (Ishii et al, 1987). The causative agents of acute conjunctivitis clinically 
diagnosed as epidemic keratoconjunctivitis (EKC) have recently been established in 
Japan. Adenoviruses are the most prevalent causative agent of viral conjunctivitis and 
were isolated from 91.2% of cases of clinically diagnosed EKC in which the aetiological 
agent was determined virologically. Apart from that, other organisms isolated include 
Herpes Simplex virus (HSV) in 4.3% and Chlamydia trachomatis in 2.5% (Uchio et 
al,2000). 
Herpesvirus infection is frequently diagnosed in dendritic or geographic corneal ulcers, 
discifonn keratitis, and keratouveitis. The virus is very rarely implicated as a cause of 
conjunctivitis alone without corneal or lid lesions. However, there have been only few 
papers describing the epidemiological features ofHSV conjunctivitis (Harding et al,1987; 
Belongia et al, 1991). 
Due to the limited reliability of clinical diagnosis of adenovirus and particularly, HSV 
induced keratoconjunctivitis , accurate laboratory investigations for this agent is often 
1 
valuable. Furthermore, the availability of appropriate treatment for HSV and together 
with the potentially serious residual morbidity of these infections clearly justify the need 
for detection of this virus in cases of keratoconjunctivitis. A study by Uchio et al (2000) 
has shown that 34.6% of HSV induced conjunctivitis cases were treated with topical 
steroid and these cases showed serious clinical findings, such as superficial punctuate 
keratitis or diffuse subepithelial corneal opacities. 
There are several problems in the diagnosis of HSV conjunctivitis at the outpatient or 
even ophthalmological clinics. Firstly, uncommon cases of HSV ocular infection 
presenting as acute follicular conjunctivitis are clinically indistinguishable from other 
more likely causes such as adenoviruses. Secondly, even though viral culture remains the 
'gold standard' for definite diagnosis of HSV conjunctivitis and allows further 
characterization of the causative agent, the pitfalls of this conventional technique are 
many. The sensitive cells for culture isolation ofHSV, such as Vero, human embryonic 
kidney, and primary rabbit kidney, are different from those for adenovirus, HEp-2, HeLa 
and A549. Therefore, if these cells are not adopted for culture isolation ofHSV, it cannot 
be isolated. In addition, cell culture isolation requires viable organisms necessitating 
special transport media and prompt transport of specimens from patient to laboratory, as 
well as it is costly and time consuming. 
The emergence of new molecular methods adapted to the field of medical microbiology 
has recently led to improvement of diagnostic procedures. This highly sensitive and 
specific method, known as polymerase chain reaction (PCR) was developed to detect a 
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single copy of a gene. It has been applied in a variety of biomedical research studies, 
including viral detection in many ocular inflammatory diseases. Owing to the sensitivity 
and speed of PCR, and the need of small sample volume, the technique has been shown 
to be of great value and offers great advantage compared to conventional method in the 
diagnosis of viral infections and thus it is one of the diagnostic method used for the 
diagnosis of herpesviruses. 
A study to determine the sensitivity and specificity of culture and the PCR for detecting 
HSV -1 in the cornea of patients undergoing penetrating keratoplasty was done by Kaye et 
al (2000). It was reported that the sensitivity and specificity of PCR for HSV -1 was 82% 
and 78% respectively whereas the sensitivity and specificity of culture was 2% and 100% 
respectively. In a study by Kowalski et al (1993), utilizing cell culture as a gold standard 
test, PCR was shown to be significantly more sensitive (95%) in diagnosing herpetic 
ocular disease than by clinical examination. Another study performed by Hidalgo et al 
(1998) in which nested PCR (nPCR) versus viral culture as method and tear film versus 
corneal scrapings as specimen was evaluated in the diagnosis of herpetic 
keratoconjunctivitis. Overall there was no significant difference between the detection 
rate for corneal scrapings (85%) and tear film (75%). In both types of specimens nPCR 
showed a higher detection rate than viral cultures (corneal scrapings: 87.5% vs 31.25%; 
tear film: 75% vs 12.5%). 
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Threefore, with this study, we hop~ to pick up more cases ofHSV induced conjunctivitis 
which may be mistakenly diagnosed as adenoviral conjunctivitis and hence proper 
treatment can be instituted. 
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1.1 OBJECTIVES 
1.1 OBJECTNES 
1.1.1 GENERAL OBJECTIVE 
To detect the viral conjunctivitis in HUSM caused by herpes simplex virus 
using a polymerase chain reaction method 
1.1.2 SPECIFIC OBJECTIVE 
i. To determine the prevalence of viral conjunctivitis caused by herpes 
simplex virus in HUSM using a polymerase chain reaction method. 
ii.To identify common clinical features of viral conjunctivitis caused by HSV 
detected by polymerase chain reaction method. 
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2. BACKGROUND 
2. BACKGROUND 
2.1 VIRAL CONJUNCTIVITIS 
Viral infections are a common cause of acute conjunctivitis and a variety of viral antigens 
have been incriminated, including adenovirus, vaccinia, herpes simplex virus, and herpes 
zoster virus. Each of these agents have been incriminated to affect the epithelium of both 
the conjunctiva and the cornea; as a result, epithelial keratitis is a frequent 
accompaniment of viral conjunctivitis (Diamante & Leibowitz, 1998). 
Manifestation of viral conjunctivitis may vary from one disease process to another. 
However, by and large, patients with viral conjunctivitis complain of a red eye, ocular 
irritation, foreign body sensation, and watery discharge; photophobia and visual loss 
usually signal corneal involvement. They can either present unilaterally or bilaterally. 
History of recent exposure to individual with red eye are frequently reported (K.rachmer 
et a1,2000; Diamante & Leibowitz,1998; Catania,1995). 
Viral conjunctivitis tends to persist for approximately 2 to 4 weeks and usually has a 
longer course than most types of acute bacterial conjunctivitis. Commonly, a viral 
etiology is characterized by conjunctival hyperemia with an acute follicular conjunctival 
response and preauricular lymphadenopathy (Krachmer et al,2000; Diamante & 
Leibowitz, 1998; Catania, 1995) 
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In general, a viral keratitis is characterized by punctate epithelial erosions that stain 
prominently with fluorescein and often are accompanied by punctate infiltrates in the 
epithelium. If the conjunctivitis persists or is severe, there may be a disturbance in the 
anterior stroma beneath the epithelial abnormalities. The stromal abnormalities may be 
ephemeral and resolve despite persistent epithelial keratitis, or, as in the case of 
adenovirus infection, they may persist for a period of years, long after the epithelial 
changes have resolved The punctate epithelial changes rarely are sufficiently distinct 
morphologically to permit identification of a specific type of virus as the etiologic agent 
(Diamante & Leibowitz et al, 1998). 
2.2 HERPES SIMPLEX VIRUS : STRUCTURE 
According to the International Committee on Taxonomy of Viruses, HSV is a member of 
the family Herpetoviridae and the genus Herpesvirus. Complete virus particles are 
approximately 180 to 200 run in diameter and consist of: 
1) a cylindrical core structure around which the viral DNA is wound. 
2) An icosahedral capsid approximately 85 to 110 run in diameter. 
3) A granular zone or tegument which surrounds the capsid. 
4) An envelope, which is derived from the host cell as particles bud from the nuclear 
membrane. 
HSV is relatively sensitive to heat and must be stored at -70C if infectivity is to be 
preserved for significant length of time. Like other enveloped viruses, HSV is readily 
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inactivated by lipid solvents such as ether, chlorofonn and alcohol. The virus is also 
sensitive to a variety of radiant energy and to many proteolytic enzymes. 
Infection by HSV begins with the attachment of the virus to a cellular receptor, which 
may differ for HSV-1 and HSV-2. The virus penetrates the cell via fusion of the viral 
envelope with the plasma membrane, followed by transcription of the HSV genome. This 
will result in production of messenger RNA (mRNA) which eventually lead to the 
synthesis of viral proteins that takes place in the cytoplasm. The proteins (structural and 
some non structural) are transported back to the nucleus where the nucleocapsid are 
assembled (Mattison et al, 1991 ). Among the nonstructural proteins which are coded for 
HSV DNA are DNA polymerases and a thymidine kinase. Inhibition of the functions of 
these enzymes has proven to be an effective method of antiviral chemotherapy in man. . 
2.3 HERPES SIMPLEX VIRUS : EPIDE:MIOLOGY 
Herpes simplex virus (HSV) is the commonest infective cause of blindness in many 
developed countries, where it has been reported with incidence of between 5.9 to 20.7 
episodes per 100 000 person-years and this appears to be increasing (Dawson & 
Togni,1976; Liesegang et al,1989) 
Initial ocular HSV episodes included incidences of 54% blepharitis or conjunctivitis, 63% 
epithelial keratitis, 6% stromal keratitis and 4% intraocular inflammation (iritis and 
uveitis). Age-adjusted rates by sex were comparable and there was no seasonal trend in 
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incidence, although rates increased in time.(Liesegang et al, 1989) However, Darourgar 
et al (1985) reported blepharoconjunctivitis in 93%, dendritic keratitis in 15% and 
disciform keratitis in 2% of the patients in their series. 7% had conjunctival involvement 
alone without lid or corneal lesion, and 15% developed chronic blepharoconjunctivitis 
that persisted occasionally for months. 
Liesegang and coworkers reported that recurrence rates assessed by life-table methods 
after the first episode were 9.6% at 1 year, 22.9% at 2 years and 63.2% at 20 years. 
Recurrence rates appeared to rise following repeated episodes. Ocular herpes simplex 
affecting both eyes at the same time and/ or different episodes were seen in 11.9% of 
cases. One fifth of patients had lid involvement alone, while a third had solely superficial 
corneal involvement (Liesegang, 1989). Study by Wishart et al (1984) reported that 
conjunctivitis with lid lesions was the most common form of recurrence of ocular herpes 
simplex i.e 83% of recurrences; acute follicular conjunctivitis without lid lesions was also 
more frequent (17.0 %) than dendritic keratitis (9.0 %) as a form of recurrence. There is 
evidence from other studies that herpes simplex virus may constitute up to 23% of acute 
conjunctivitis presenting at ophthalmology outpatients clinics and may frequently present 
without corneal or lid lesions. 
Humans are the only natural reservoir of herpes simplex virus. Sources of infection are 
by direct contact with infected lesions, salivmy droplets from children and adults with 
active disease (cold sores) and via the saliva or fomites of asymptomatic, virus shedding 
carriers. Iatrogenic sources of infection are the physician's unwashed hands and 
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contaminated Schi.atz or applanation tonometer head. HSV is viable for up to 2 hours on 
a dry tonometer head and up to 8 hours on one kept moist. Swabbing the tonometer with 
70% isopropyl alcohol is 100% effective in killing the virus, and this should be done 
between patients along with hand washing with a soapy solution (Ventura et al, 1987). 
By the age of 5 years, 60% of all children have been infected with type 1 (oral) HSV, 
usually through the mouth or nares, with only about 6% developing clinically apparent 
primary disease. Less than 1% of primary HSV presents as overt ocular disease. The oral 
and nasal portals of entry allow the virus access to the trigeminal ganglion, which also 
innervates the eye. The vast majority of first ocular (not primary) or recurrent ocular 
herpes infections are due to reactivation of latent trigeminal ganglion virus with 
subsequent appearance of the virus in the eye alone or associated with eruption of cold 
sores around the mouth or nose. 
2.4 HERPES SIMPLEX VIRUS (HSV) CONJUNCTIVITIS 
Herpes simplex virus (HSV) conjunctivitis can either occur in primary ocular herpes 
simplex that is an acute first HSV infection of the nonimmune host, or recurrent ocular 
herpes simplex whereby the ocular infection occurs after reactivation of the latent virus 
in the ophthalmic division of the trigeminal ganglion. 
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HSV conjunctivitis is typically characterized by follicular conjunctivitis which may be 
seen with or without, ipsilateral preauricular lymphadenopathy. It can also occurs without 
involvement of other ocular structures such as the eyelids or cornea. 
Lid lesion, when present, exhibits an erythematous base and may ulcerate with a honey-
yellow crusty border. Patients usually complain of an acute onset of tearing, burning, 
foreign body sensation and photophobia as well as blurring of vision if epithelial keratitis 
also develops (Leibowitz & Koleini, 1998). The bulbar and palpaberal conjunctiva are 
usually diffusely hypereamic. Rarely a pseudomembrane will form which is another 
potential similarity to adenoviral conjunctivitis, and there may be some atypical 
superficial punctate keratitis or more severe corneal disease. 
Because HSV and adenoviral conjunctivitis are often indistinguishable in the absence of 
corneal or lid involvement, unilaterality is an important clinical sign, with epidemic 
keratoconjunctivitis (EKC) more commonly becoming bilateral (Diamante & Leibowitz , 
1998). Uchio et al (2000) reported, from their study, that 87% of HSV conjunctivitis was 
noted to be unilateral and early corneal lesions and preauricular lympadenopathy were 
less frequent in HSV conjunctivitis than in adenoviral conjunctivitis. 
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2.5 BACTERIAL AND OTHER NON-VIRAL CONJUNCTIVITIS 
Bacterial conjunctivitis typically presents with acute onset of ocular symptoms which 
consist of burning sensation, eye irritation and matted eyelids on awakening. Clinical 
signs include variable degrees of conjunctival injection, papillae, and mucopurulent 
discharge with no preauricular lympadenopathy except in hyperacute cases. Definitive 
diagnosis is based on stains and cultures after swabbing the conjunctiva. 
The three most common pathogens 1n bacterial conjunctivitis are Streptococcus 
pneumoniae, Haemophilus injluenzae and Staphylococcus aureus. Infections with 
S.pneumoniae and H. influenzae are more common in children, while S.aureus most 
frequently affects adults. (Jackson, 1993) 
Bacterial conjunctivitis is usually treated with a topical broad-spectrum antibiotic 
solution ( e.g.,trimethoprim/polymyxin B, ciprofloxacin, ofloxacin) or an antibiotic 
ointment (e.g., bacitracin, erythromycin, polymyxin B, ciprofloxacin ). 
Other causes of conjunctivitis can be noninfectious in origin and allergic conjunctivitis is 
one of the causes. Allergic conjunctivitis encompasses a spectrum of distinct clinical 
conditions usually characterized by itching which is painless with no history of exposure. 
Clinical signs consist of conjunctival hyperemia with chemosis and eyelid swelling but 
preauricular lympadenopathy is absent. The personal or family history is often positive 
for other atopic conditions, such as allergic rhinitis, asthma or eczema. Treatment 
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measures include allergen avoidance, cold compresses, vasoconstrictors, antihistamine 
drops, topical nonsteroidal an~i-inflammatory agents and mast-cell stabilizers. 
Toxic conjunctivitis or chemical conjunctivitis is another example of noninfectious 
conjunctivitis. It is caused by direct contact by with noxious fumes, particles, or chemical 
fluids. It can result in a red eye with tearing, pain, and sensitivity to light. The severity 
depends on the type of chemical and the length of time the eye was exposed. Treatment 
includes removal of toxic substance and institution of preservative-free lubricating tears 
and ointment. 
2.6 HSV CONJUNCTIVITIS :LABORATORY DIAGNOSIS 
Diagnosis of ocular viral disease is usually made based on clinical impression only. 
However, most of the time, difficulty will arise in achieving clinical diagnosis of HSV 
conjunctivitis whereby it is hard to differentiate between adenovirus or HSV as the 
causative organism in viral conjunctivitis, based on clinical features alone. Therefore 
accurate laboratory investigation for these agents in conjuctival swabs is often valuable. 
Sensitivity, specificity, speed and availability determine the choice of a diagnostic test for 
HSV infection. 
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2.6.1 VIRAL CULTURE 
The presence of viable virus in a clinical specimen as determined by virus isolation in 
culture is the most definitive evidence of HSV infection, particularly within the context 
of identifying a reservoir for virus transmission. Samples of ocular lesions are taken on a 
swab. For best results, specimens should be inoculated within 1 hour after collection. 
Otherwise, they should be kept in transport medium and refrigerated or frozen (at -70°C) 
in order to preserve the specimen. Examples of transport medium include Eagle's 
minimal essential medium, Dulbecco's minimal essential media and Hanks Balanced Salt 
Solution. The transport medium is supplemented with fetal bovine serum and also 
antibiotics. 
Primary cells are generally more sensitive than the established lines. The most sensitive 
are primary rabbit kidney (PRK) and human embryo cells. Commonly used cell lines are 
human lung fibroblasts i.e. lvffi.C-5 and human lung carcinoma cells i.e. A549 (Carter et 
al, 1997). 
Cytopathic effect (CPE) can be seen within 18 h p.i., but it generally takes 2 to 3 days 
(depending on the sensitivity of the cells and the amount of virus inoculated). Cultures 
are routinely kept for 14 days before negative results are reported. HSV causes a 
characteristic CPE consisting of rounded refractile cells. If hematoxylin-eosin stain is 
applied, the cells exhibit eosinophilic intranuclear inclusions. Polykaryocytosis depends 
on the virus strain and the cell type. 
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Result may be confounded by the presence in the specimens of other viruses that cause a 
similar CPE, such as adenovirus, a common isolate in ocular specimens. To address this 
problem, at least two cell types that differ in the ability to support the growth of these 
viruses should be used routinely for viral culture, for example :MR.C-5 and A549 cells. 
HSV grows in lv1RC-5 cells; adenovirus does not. In A549 cells, adenovirus CPE is first 
seen on day 4 or 5; that ofHSV is seen on days 1 through 3. Ultimately, however, virus 
identification can be done only using specific antisera in an appropriate immunologic 
test. 
However, the pitfalls of these conventional techniques are numerous. Cell culture 
isolation requires viable organisms necessitating special transport media and prompt 
transport of specimens between patient and laboratory. In addition, it is costly as well as 
time consuming and hence, cause a major limitation when rapid diagnosis is essential or 
required. Then again, it remains the "gold standard" of herpes simplex laboratory 
diagnosis, as isolation of an infectious agent is definitive and allows further 
characterization. 
2.6.2 ANTIGEN DETECTION 
Because the quantity of virus present in clinical specimens is variable (depending on 
lesion status and collection procedure), antigen detection may provide an alternative to 
virus culture which has the ability to identify nonviable virus. The basic principle is that 
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antigens in the lesion interact with the added HSV antibody, producing complex that may 
be detected by a variety of methods such as immunofluorescence (IF) or 
immunoperoxidase (IP) staining, enzyme immunoassay (EIA) (viz., ELISA), or 
radioimmunoassay (RIA). Recently available monoclonal antibodies to HSV proteins 
have improved the specificity of these assays and provided the necessary tools for 
differentiation between the two HSV serotypes. 
Antigen detection assays are rapid and relatively inexpensive, but there is still uncertainty 
as to th~ir sensitivities and specificities. A study by Uchio et al (2000) showed that there 
was no cases of acute follicular conjunctivitis demonstrating a positive result for HSV by 
using a direct immunofluorescence test (Microtrak HSV 1/ HSV 2), on conjuctival swab 
samples. However, the fluorescence antibody (FA) test was positive in all strains isolated 
by cell culture. 
Pramod et al (1998) had carried out a study to assess the diagnostic value of indirect 
immunofluorescence (IF) procedure in comparison with routine viral culture for the 
diagnosis of herpes simplex virus induced keratitis, from samples of corneal scrapings. 
Virus specific antigen was detected by indirect IF in 31.42% of cases and in contrast only 
20% of cases had positive viral isolation which sometimes took as long as a week to 
show a cytopathogenic effect (CPE). Therefore, it was concluded that antigen detection 
by indirect IF is rapid, specific and sensitive technique for demonstrating HSV -1 antigen 
in corneal scrapings from Herpes simplex keratitis patients. 
16 
For direct examination of clinical specimen, the scrapings are placed in a drop of 
phosphate-buffered saline (PBS) on slides. After drying, the cells are fixed with acetone, 
washed with PBS and stained with HSV antibody conjugated to a detector molecule such 
as fluorescein isothiocyanate (FITC). If monoclonal antibodies are used, fixation may 
have to be in ethanol or methanol, since some epitomes epitopes are acetone sensitive. 
Detection of fluorescence indicates HSV presence. The indirect assay uses unconjugated 
HSV antibody followed by the appropriate FITC-conjugated anti-immunoglobulin. 
Lee et al (1990) had compared the HERPCHEK TM ELISA method with virus culture and 
direct immunofluorescence in the rabbit model ofHSV keratitis. It was shown that direct 
immunofluorescence provided lower sensitivity than the HERPCHEK1M test or virus 
culture in animals whose disease was untreated. 
2.6.3 POL YlvffiRASE CHAIN REACTION 
In the history of molecular biology, polymerase chain reaction (PCR) which was 
originally described by Saiki et al in 1985 ( Lohmann et al,2000 ), is an extremely 
sensitive method designed to amplify and detect specific or selected target DNA 
sequences. 
Basically, PCR is an in vitro method of the enzymatic synthesis of a specific DNA 
sequence, using two oligonucleotide primers that hybridize to opposite strands and flank 
the origin of interest in the target DNA sequence, usually one hundred to several base 
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pairs (Erlich HA, 1989). This technique has been used primarily in research and clinical 
studies of genetic, infectious disease, forensic medicine and oncology. Repetitive cycles 
will synthesise an exponential accumulation of specific fragment and hence the amplified 
DNA sequence can be detected ( Byrne et al, 1995 ). 
2.6.3.1 CLINICAL SAMPLE 
Samples can be obtained from cerebrospinal fluid, aqueous, vitreous humor, blood or 
tissues. Samples to be tested by PCR for the presence of infectious agent can be frozen 
because only DNA, and not viable organisms, is required. A temperature of -20°C is 
acceptable for freezing, but -70°C or -80°C is preferable, especially for longer-term 
storage. (Byrne et al, 1995) 
2.6.3.2 PCR PROTOCOL 
The PCR is based on the repetitive cycling of three reactions (Figure 1 ). Each cycle 
consists of three steps: denaturation of the target DNA by heating to a high temperature, 
annealing of oligonucleotide primers to the target DNA, and the synthesis of two new 
strands of DNA by a DNA polymerase. If a sequence of RNA is to be amplified, a copy 
of it must first be made (eDNA) by a reverse transcriptase before beginning the PCR. The 
oligonucleotide primers used average 18 to 25 bases in length and can be easily 
synthesized with automated equipment. In practice two specific primers are used which 
flank the region of interest. One primer is complementary to the coding strand and the 
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other complementary to the non-coding strand. Synthesis of the DNA occurs along both 
the coding and non-coding strands from the primer binding sites. As these steps are 
repeated, the DNA defined by the primers undergoes exponential amplification as the 
newly synthesized strands themselves become templates. 
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Figure 2.1: Polymerase chain reaction. 
ab represents segment of DNA which is amplified. Each cycle consists of denaturation of 
the DNA, annealing of the primers, Pl and P2 to the DNA and the subsequent synthesis 
of new strands. Segment ab/ba accumulates at an exponential rate by acting as its own. 
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2.6.3.2.1 DNA Extraction 
In preparation for the PCR procedure, whole genomic DNA must be extracted from the 
sample (fresh or frozen) to be tested. There are several means to accomplish this. In 
general, fluids such as cerebrospinal fluid and aqueous or vitreous humor can be heated at 
95°C for 30 minutes. Samples such as blood or tissue that contain cells are treated with 
proteinase K (final concentration, 2501J.g/ml) I detergent solution for 1 hour at 56°C and 
then heat denatured at 95°C for 10 minutes. The detergent solubilizes the cell 
components and the proteinase K digests the proteins. Commercially available products 
such as Gene Releaser (Bio Ventures Inc., Murfreefboro, Tennesee) can also be used to 
release genomic DNA. Alternatively, DNA may be purified from the samples to be tested 
by PCR by using a phenol I chloroform extraction procedure (Byrne et al, 1995) 
2.6.3.2.2 PCR Amplification 
Amplifications are performed in a small volume, usually 1001J.L or less. A PCR reaction 
mix is prepared that contains 
1) lOX amplification buffer, standard buffer contains 0.5 mmol/L potassium 
chloride, 10 mmol/L Tris HCL ( pH 8.3 ), 15 mmol/L magnesium chloride and 
0.1% gelatin. The free magnesium concentration is critical for functioning of the 
DNA polymerase and should be optimized for each primer I target system. 
21 
2) DNA polymerase from the bacterium Thermus acquaticus ( Taq polymerase ) 
survives the repeated high-temperature denaturations in the PCR procedure and is 
used at a concentration of approximately 2 units, which is depleted after 
approximately 30 amplifications cycles. 
3) Equimolar concentrations of all four deoxynucleotide triphosphate ( dNTP ) 
[dNTPs: d.ATP ( 2'-deoxyadenosine 5-triphosphate ), dCTP ( 2'-deoxycytidine 5'-
triphosphate), dGTP ( 2'-deoxyguanosine 5'- triphosphate ), dTTP ( 2'-
deoxythymidine 5'triphosphate )], 200J.1moll L each. 
4) Oligonucleotide primers: 1 J.lmol/L is usually sufficient for approximately thirty 
amplification cycles. For target DNA to be amplified by PCR, the nucleotide 
sequences at either end of the DNA piece must ~e known. Primers are shortpieces 
of single-stranded DNA ( preferably twenty to twenty-four nucleotides in length ) 
that are complementary to these lmown sequences. Primers should ideally have a 
guanine-cytosine content of approximately 50%, should not contain guanine-
cytosine-rich stretches, and should not contain any homologous regions between 
the oligonucleotides that constitute the primer pair. Primer can be made 
synthetically and are designed to anneal to the end regions of the target DNA to 
serve as an initiation point for synthesis. 
5) The sample to be tested 
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6) Sterile distilled water to bring the volume to I 00 J.LL. 
Once the water, buffer, deoxyribonucleoside triphosphates (dNTPs), pnmer pairs, 
polymerase, and sample are combined in a microcentrifuge tube, the mixture is 
microcentrifuged to consolidate the reagents and is overlaid with 100 J.LL mineral oil to 
prevent evaporation of the mixture during amplification. A positive control and a 
negative buffer control are included with each reaction. (Byrne et al, 1995) 
2.6.3.2.3 Detection Of Amplified Products 
Amplified DNA is generally separated and visualized using ethidium bromide I agarose 
gel electrophoresis. DNA-grade ultrapure agarose, polyactylamide, or high-density 
(NuSieve, InterMountain Scientific, bountiful, Utah) gels can be used. Ethidium bromide 
can be added during preparation of the gel and is used at a final concentration of 0.5 
J.Lg/ml, or the gel may be stained after electrophoresis. The samples are mixed with a 1 OX 
loading buffer containing glycerol and bromophenol blue and loaded into the wells of the 
gel. Molecular weight markers are also mixed with loading buffer and run in parallel with 
the samples. (Byrne et al, 1995) 
Electrophoresis is done in Tris-Borate/ethylenediaminetetra-acetic acid {EDTA) buffer 
until the bromophenol blue dye approaches the bottom of the gel. The amplified DNA 
fragments then are visualized using a long-wave ultraviolet light. The sizes of the 
amplified bands are determined by comparing their locations relative to the molecular 
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weight marker panel. The expected size of the amplified fragments of the positive control 
is predetermined from the known DNA sequence. Test samples demonstrating positive 
bands of the same molecular weight as the control are considered positive. The identity of 
the amplified product may be further confirmed by a method such as dot blot, slot blot, or 
Southern blot hybridization with a 32P-end-Iabeled probe.(Byme et al, 1995) 
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2.6.3.3 :MINIMIZE RISK OF CONTAMINATION 
Because of the extreme sensitivity of the system, it is essential to avoid false-positives, 
which could occur by cross contamination between samples or by contamination of 
reagents with amplified products or positive controls. Some general precautions to 
minimize the risk of contamination include performing the initial processing in a biologic 
safety hood not used for any other PCR-related procedures. All reagents should be 
prepared in another biologic safety cabinet, using materials dedicated solely for PCR, and 
should be aliquoted into sterile tubes before use. Amplified products and procedures for 
their detection and confmnation should be separated from the other reagents and are 
preferably handled in another laboratory. (Byrne et al, 1995) 
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2.6.3.4 CLINICAL INDICATION 
PCR is rapidly becoming a major tool in the diagnostic repertoire for infectious diseases, 
and it promises to play a role in the diagnosis and monitoring of cancer, in clinical 
genetics, and in forensics (Campbell et al, 1992). 
Amplification techniques have been used for the diagnosis of pathogens that are difficult 
or impossible to grow, such as Mycobacterium leprae, Borrelia burgdorferi and 
Toxoplasma gondii, for the rapid identification of slow-growing pathogens such as 
Shigella spp. from a dense background of normal flora. They have been extensively used 
in viral diagnosis for a wide range of pathogens such as human immunodeficiency virus 
type 1 (HIV -1 ), most notably; herpes simplex virus and adenovirus. Nucleic acid 
amplification has particular value in retroviral studies, since latent, unculturable 
proviruses can be detected easily. These methods are also useful in epidemiologic 
analysis, since suitable primers may be used to discriminate between strains of the same 
organism (Campbell et al, 1992 ). 
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2.6.3.5 ADVANTAGES OF PCR 
The speed, sensitivity and specificity of amplification techniques allow rapid, direct 
diagnosis of the diseases which formerly could be diagnosed only slowly, indirectly ( eg., 
by serology), at great expense, or not at all (Campbell et al, 1992). 
Because amplification methods directly detect minute quantities of pathogen genetic 
material, they can provide acute-phase diagnosis with high sensitivity without the need to 
await antibody formation (Campbell et al, 1992) 
Amplification methods will detect a pathogen only if nucleic acid from that organism is 
actually present, so confusion with infections in the distant past is unlikely. It is currently 
unclear, however, how long DNA or RNA persists after an infection is cleared by host 
immunity or therapeutic intervention. ( Campbell et al, 1992 ) 
It is likely that the species specificity of amplification methods will be used to resolve 
problems with cross-reactivity in diagnosis of diseases such as spirochetal infection. 
(Campbell et al, 1992) 
27 
2.6.3.6 DISADVANTAGES OF PCR 
Serology remains the diagnostic method of choice in conditions such as cysticercosis, in 
which the infective organism is in a sequestered site, making it difficult to obtain target 
nucleic acid (Campbell et al, 1992). 
Serology may also be used to determine whether a patient has ever been exposed to a 
pathogen, regardless of whether the infecting organism is actually present, whereas 
amplification methods require the presence of the organism. (Campbell et al, 1992) 
An antibody response also provides information on the pathogenicity or invasiveness of 
an organism such as Legionella sp. In which may be normally present in the environment 
and thus contaminate clinical specimens. Amplification is unlikely to discriminate 
between colonization and infection ( Campbell et al, 1992 ). 
Culture allows for the investigation of special characteristic such as strain pattern or 
virulence factors which may be difficult or impossible to determine by amplification 
alone (Campbell et al, 1992) 
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2.7 HSV CONJUNCTIVITIS: TREATMENT 
HSV conjunctivitis is benign and self limiting. However, topical antiviral therapy with 
either ointments or drops such as trifluridine or acyclovir is given, in part to prevent 
spread of the infection to the corneal epithelium. 
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3. MATERIALS AND 
METHOD 
3. MATERIALS AND METHOD 
3.1 RESEARCH STRATEGY 
The study design was a cross sectional study. 
3.2 POPULATION, SETTING AND TIME 
Study population : Patients with conjunctivitis attending Ophthalmology clinic and 
Outpatient clinic, HUSM 
Period of study : November 2002 to November 2003 
Place of study : Ophthalmology Clinic, HUSM 
Outpatient Clinic, HUSM 
Microbiology Lab, HUSM 
3.3 SAMPLING N.IETHOD AND SAMPLE SIZE 
Sampling of patients according to the non-randomised sampling method whereby all the 
cases clinically diagnosed as viral conjunctivitis were included in this study. 
Sample size was calculated based on a single proportion formula 
n=(~a J2 XPX(l-P) 
p = HSV conjunctivitis prevalence ( 4.3 % ) 
= ( 1.96 J 2 X 0.043 X ( 1- 0.043 ) 
0.05 
= 63 n=70 
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3.4 SELECTION CRITERIA 
3.4.1 INCLUSION CITERIA 
- All clinically diagnosed viral conjunctivitis patients; as elaborated in the 
definition of tenns; from HUSM. 
- Patient or parents consented for conjunctival scraping using conjunctival 
swab. 
- Patient 7 years old or more so as to be able to give infonnation regarding 
symptoms. 
3.4.2 EXCLUSION CRITERIA 
Clinically diagnosed primary microbial conjunctivitis patients. 
Clinically diagnosed non-infective conjunctivitis, eg: chemical related, 
allergic conjunctivitis. 
- Patient started on systemic or topical antiviral treatment. 
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3.5 ETHICAL PROBLEM 
Conjunctival scrapping using conjunctival swab is not a regular procedure performed in 
cases of clinically diagnosed viral conjunctivitis. Therefore a written consent was 
obtained from all patients or parents after explanation ( refer to Form A ). This study was 
approved by the Research and Ethical Committee, School of Medical Sciences,USM and 
also received an IRPA short term grant (304 I PPSP I 6131265) from the Bio-Medical 
Sciences and Health Committee, Universiti Sains Malaysia, Pulau Pinang on the 11th 
October 2002. 
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3.6 DEFINATION OF TERMS 
3.6.1 Clinically diagnosed viral conjunctivitis 
Clinically diagnosed viral conjunctivitis is defined based on its signs and symptoms. 
History may include the onset and spread of conjunctivitis, history of any exposure, 
symptoms of watery discharge and ocular irritation or foreign body sensation, as well as 
ruling out any noninfective causes. On examination, the conjunctivitis is shown as 
inflammatory processes involving the conjunctiva characterized by a red eye, visible 
evidence of dilated conjunctival vessels and the resultant hyperemia with varying degree 
of conjunctival oedema and mainly conjunctival follicular reaction ~th presence of 
serous or mucoid discharge. Patient may also have tender ipsilateral preauricular 
lympadenopathy or pseudomembrane (Krachmer et al, 2000; Diamante,Leibowitz, 1998). 
In this study, kerato and blepharoconjunctivitis are included. 
3.6.2 Herpes simplex virus ( HSV ) conjunctivitis 
One form of viral conjunctivitis whereby the inflammatory process of the conjunctiva 
occurs as a result of active herpes simplex virus infection which was detected by 
polymerase chain reaction ( PCR ) method and it can occur with or without involvement 
of other ocular structures such as eyelids or cornea. 
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3.6.3 Grading of conjunctival injection 
The grading of conjunctival injection was as follows : 
Grade Conjunctival injection 
Mild Localize conjunctival hyperemia 
Moderate Diffuse conjunctival hyperemia 
Severe Diffuse conjunctival hyperemia with chemosis and occasionally 
subconjunctival haemorrhage 
(American Academy of Ophthalmology, 1982) 
3.6.4 Oligonucleotide Primer 
Short synthetic DNA molecule used as a probe or a primer of DNA synthesis in 
laboratory. In this study, commercial primers to detect HSV typel/2 was used ( HSV 
Type 1/2, DNA polymerase, primer set kit; Maxim Biotech ). 
3.6.5 Polymerase Chain Reaction method positive for herpes simplex virus 
Polymerase chain reaction ( PCR ) is considered positive for herpes simplex virus when 
there is presence of amplified target sequence ( PCR product ) which is presented as a 
band of expected size on agarose gel electrophoresis using commercial primers provided 
by herpes simplex virus type 1/2, DNA polymerase, primer set kit ( Maxim Biotech ) 
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3.6.6 Viral transport media 
Viral transport media is a medium which is used to ensure the viability and stability of 
the virus taken from conjunctival swabs during transportation to the lab. The transport 
media used in this study is Hanks Balanced Salt Solution. 
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3. 7 INSTRUMENTS 
3. 7.1 Microcentrifuge 
Microcentrifuge is a machine which is used to centrifuge the samples or specimens 
during DNA extraction procedure. 
3. 7.2 UV spectrophotometer 
UV spectrophotometer is a machine which is used to measure DNA concentration and its 
purity after extraction of the DNA from samples of conjunctival swab. 
3. 7.3 PCR thermal cycler 
PCR thermal cycler is a machine used for amplification tn PCR . In this study, 
EppendorfMastercycler Gradient was used. 
3. 7.4 Agarose gel electrophoresis apparatus 
Agarose gel electrophoresis apparatus is an apparatus used to run the PCR product and 
hence, to analyse the amplified samples. 
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2.10.2003 
Figure 3. 1: UV spectrophotometer 
2.10.2003 
Figure 3.2: Microcentrifuge 
37 
l it( I A ll l U I\ 
2.10.2003 
Figure 3.3 : PCR thermal cycler 
Figure 3.4: Agarose gel electrophoresis apparatus 
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3.8 :METHODS 
3.8.1 CLINICAL SA1\.1PLE COLLECTION 
All cases of conjunctivitis were screened at the outpatient and ophthalmology clinic 
between November 2002 and November 2003 and were referred to one ophthalmic 
medical officer in ophthalmology clinic. To confirm diagnosis, clinical history was again 
taken and patients were examined under slit-lamp. Attention was paid to the signs in the 
tarsal and bulbar conjunctivae, fornices, and lids. The cornea was examined and stained 
with fluorescein to detect any epithelial abnormality. Based on selection criteria, seventy 
patients were identified to have clinically diagnosed viral conjunctivitis. Clinical features 
of the viral conjunctivitis cases were then documented. 
Conjunctival swab was obtained by scrapping the superior and inferior fornices with a 
sterile swab after instillation of0.4% guttae Novesine (local anaesthesia) to the affected 
eye, or more severe eye if both were affected. The scraped specimen was placed in a 1. 5 
m1 microcentrifuge tube containing 1 ml viral transport medium and was stored in the 
freezer at 4 °C. It was then carried to the laboratory on the same day in an ice box. In the 
laboratory, the specimen was stored at - 40°C until processed for PCR. 
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3.8.2 DNA EXTRACTION 
DNA extraction was carried out according to the Nucleospin Kit ( Clontech, USA ). The 
samples were thawed, homogenized by vortexing and then transferred to a 1.5 ml 
microcentrifuge tube. The samples were pelleted by centrifugation at 12 000 x g for 5 
minutes. 
The supernatant was aspirated and each pellet was resuspended in 180 ~1 of buffer T1 ( 
lysis buffer provided by the Nucleospin Kit ). Sample was vortexed to mix. 25 J.ll of 
proteinase K was added to each sample and mixture was again vortexed and later, 
incubated at 56 °C for 3 hours in a shaking waterbath. 
After incubation, sample was vortexed and 200 J.ll buffer B3 (component ofNucleospin 
Kit ) was added. The mixture was mixed vigorously and incubated at 70 °C for 10 
minutes. 
Subsequently, 210 ~I ethanol 95 % was added to the sample and immediately vortexed to 
avoid precipitation. The sample was then applied to a Nucleospin Tissue column which 
was placed in a 2 ml collecting tube, followed by centrifugation for 1 minute at 6 000 x g. 
The flowthrough was discarded and the column was placed back into the collecting tube. 
Next, 500 ~I of buffer B5 (component ofNucleospin Kit, which was mixed with 95% 
ethanol ) was added and centrifuged for 1 minute at 6 000 x g with the flowthrough 
40 
discarded after sptnntng. This washing step was repeated and followed with 
centrifugation at 6 000 x g for 2 minutes. Residual ethanol was removed during this step. 
The Nucleospin Tissue Column was then placed into a clean 1.5 microcentrifuge tube. 
Subsequently, the DNA elution was performed by adding 100 Jll prewanned elution 
buffer BE ( 5mM Tris/Cl ; pH 8.5- component ofNucleospin Kit) which was incubated 
at 70 °C for 4 minutes, to the Nucleospin Tissue column and centrifuged at 6 000 x g for 
1 minute. Finally, the amount of DNA in the sample was determined using a UV 
spectrophotometry. The extracted DNA was kept frozen at -20 oc until PCR was 
performed. 
3.8.3 PCR PROTOCOLS 
PCR was carried out using Herpes Simplex Virus Type 1/2, DNA polymerase, Primer set 
kit (Cat. No.: SP-10319, Maxim Biotech. Inc.), according to the manufacturer's 
recommendation. It was perfonned in a clean room with pipettes reserved specifically for 
this purpose. 
41 
3.8.3.1 MASTER :MIXTURE PREPARATION 
250 J.ll of pre-mixed primer, provided by HSV Type 1/2 , DNA polymerase, primer set kit 
( Sequences: Alignment on database;- HSIDP & HS2POL, X04771, M16321 ) was 
added to each 750 J.Ll tube of optimized PCR buffer ( 2 mM MgC12, 15 mM Tris-HCL, 
. 30 mM KCI, 0.25 J.LM dNTPs Mix, enhancer & stabilizer- component ofHSV Type 1/2, 
DNA polymerase, primer set kit ). The Master Mixture was then aliquoted and stored at -
20°C. 
The PCR assay was perfonned under the following conditions : To 20 J.Ll of Master 
Mixture, 0.1 J.d of Taq DNA polymerase and 5 J.1l of specimen or control eDNA were 
added. The final volume was made up to 25 J.Ll with distilled water if specimen or control 
eDNA used was less than 5 J.1l. 
To detect as well as to exclude carryover or contamination of HSV DNA, positive 
controls and negative controls, respectively, were included for every set of PCRs. The 
positive control consisted of a clone containing PCR fragment which was PCR product 
derived from HSV Type 1 genomic DNA using HSV- 1012 N/ 1013 N as the primers ( 
component of Type 1/2 , DNA polymerase, primer set kit ) whereas the negative control 
consisted of deionised sterile water ( component of HSV Type 1/2 , DNA polymerase, 
primer set kit). 
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3.8.3.2 PCR REACTION PROFILES 
PCR was carried out using the following temperatures : initial denaturation at 96°C for 1 
minute, followed by 35 cycles of reaction consisting of DNA denaturation at 94°C for 1 
minute, primer annealing at 58°C for 1 minute and primer extension at 72°C for 1 minute. 
For the last cycle of PCR, the 72°C step was extended to 10 minutes. Eppendorf 
Mastercycler Gradient was used for performing the above reaction. In brief, the reaction 
profiles are shown as below : 
96 oc 
94°C 
58 oc 
72 oc 
72 oc 
1 min 
1 min 
1 min 
1 min 
10min 
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3.8.3.3 DETECTION OF PCR PRODUCT 
PCR product was run in a horizontal submerged agarose gel. 1.2 % agarose gel was 
casted on a gel casting tray using O.SX TBE ( 0.045M Tris-borate, 0.001M EDTA) with 
0.05 Jlg/ml of ethidium bromide. DNA loading buffer ( 40% sucrose in 0.5% TBE with 
0.25% orange G dye) was mixed with 10 Jll of the PCR products which were then loaded 
on to the gel to undergo electroporesis. The gel was run at 80 volt for an hour at room 
temperature. Molecular weight marker, 100 bp ladder ( provided by the HSV 1/2, DNA 
polymerase, primer set kit ) was used to detect 241 base-pair DNA fragments which were 
consistent with the size of the target HSV DNA polymerase gene fragment. The PCR 
products were visualized using UV transilluminator. 
3.8.4 FLOW CHART 
The methodology of our study was summarized by a flow chart provided, with reference 
to appendix 3. 
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2.10.2003 
Figure 3.5: Conjunctival scrapping sample in Appendorftube containing viral transport 
media 
Hioh:h , Inc. 
He rp<JS Simplex VI I llS Type 1/2 DI'JA pol 
Pr ime r Set Kit 
Figure 3.6: Primer set kit 
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Figure3.7: PCR procedure 
Figure 3.8: Agarose gel electrophoresis procedure 
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[ 241 bp -I 
M N p 1 2 3 4 5 
Figure 3.9: Ethidium bromide-stained agarose gel electrophoresis of amplified PCR 
product of samples 
Lane M : 100 bp DNA ladder 
Lane N : Negative control 
Lane P : Positive control 
Lane 1-5: Samples from conjunctival scrappings 
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3.8.5 STATISTICAL 1\.1ETHODS 
Data entry and data analysis were done by using SPSS version 10. All patients' data were 
analysed by descriptive analysis. 
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4. RESULT-S 
4. RESULTS 
4.l.VIRAL CONJUNCTIVITIS: DEMOGRAPIDC CHARACTERISTICS 
Seventy cases of viral conjunctivitis were studied over a period between November 2002 
and November 2003. All the cases were from Hospital Universiti Sains Malaysia which 
were either seen at ophthalmology outpatients or casualty clinics. 
The mean age of patients with viral conjunctivitis was 36.6 years ± 17.28. The 21 to 40 
year age group comprised the highest (45.7 %) proportion of cases among all age groups. 
Table 4.1: Distribution of viral conjunctivitis according to age 
Range of age (year) 
7 to 20 
21 to 40 
41 to 60 
61 to 80 
No of cases 
35 
30 
25 
20 
15 
10 
5 
0 
No of patients (n=70) 
7-20 
14 
32 
16 
8 
21-40 41-60 
Age group 
61-80 
Percentage (%) 
20.0 
45.7 
22.9 
11.4 
Figure 4 .1: Distribution of viral conjunctivitis according to age 
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Table 4.2 : Distribution of viral conjunctivitis according to sex 
Sex 
Male 
Female 
51% 
No of patients (n=70) 
34 
36 
49% 
Percentage (%) 
48.6 
51.4 
omale 
• female 
Figure 4.2 : Distribution of viral conjunctivitis according to sex 
There was only a slight preponderance for females which accounted for 5 1.4 % whereby 
males 48.6 %. 
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Table 4.3 ; Distribution of viral conjunctivitis according to race 
Race 
Malay 
Chinese 
Others 
No of cases 
70 
60 
50 
40 
30 
20 
10 
0 
No of patients (n=70) 
Malay 
67 
2 
1 
Chinese 
Race 
Others 
Percentage (%) 
95.7 
2.9 
1.4 
Figure 4.3 : Distribution of viral conjunctivitis according to race 
ln this study, most of the patients with viral conjunctivitis presented to our eye clinic 
were Malays (95.7 %) followed by Chinese patients (2.9%) and Eurasian heritage (1.4%). 
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4.2. HSV CONJUNCTIVITIS : DETECTION OF HSV BY PCR ~THOD 
IN VIRAL CONUNCTIVITIS 
Out of 70 patients clinically diagnosed as having viral conjunctivitis, 12 samples (17.1 %) 
from patients were positive for herpes simplex virus (HSV) by PCR method. 58 samples 
from clinically diagnosed viral conjunctivitis patients were negative by similar method. 
Therefore, in this study, the prevalence of herpes simplex infection in viral conjunctivitis 
in HUSM was found to be 17.1 % (95% CI = 8.1, 26.0). 
Table 4.4 : Result of PCR test to detect herpes simplex virus in viral conjunctivitis 
PCR test 
Positive for HSV 
Negative for HSV 
No of patients (n-70) 
12 
58 
17% 
Percentage (%) 
IJPCR positive 
•PeR negative 
17.1 
82.9 
f igure 4.4 : Result ofPCR test to detect herpes simplex virus in viral conjunctivitis 
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4.3. HSV CONJUNCTIVITIS : DEMOGRAPHIC CHARACTERISTICS 
The mean age of patients having HSV conjunctivitis was 35 .15 years ± 14.98. HSV 
conjunctivitis most frequently occurred between 21 to 40 year age group (58.3%). The 
age distribution was similar to that of viral conjunctivitis in general (Table 4.1). 
Table 4.5: Distribution ofHSV conjunctivitis according to age 
Range of age (year) 
7 to 20 
21 to 40 
41 to 60 
61 to 80 
No of cases 
7 
6 
5 
4 
3 
2 
0 
No of patients (n- 12) 
7-20 
2 
7 
2 
21-40 41-60 
Age group 
Percentage (%) 
61 -80 
16.7 
58.3 
16.7 
8.3 
- - ---------
Figure 4.5 :Distribution ofHSV conjunctivitis according to age 
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Table 4.6 : Distribution ofHSV conjunctivitis according to sex 
Sex 
Male 
Female 
58% 
No patients (n=l2) 
5 
7 
Percentage (%) 
1!1 male 
111 female 
41.7 
58.3 
Figure 4.6: Distribution of viral conjunctivitis according to sex 
A female preponderance was found in cases of HSV conjunctivitis presented to the 
ophthalmology clinic, HUSM with 58.3% females and 41.7% males. 
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Table 4.7 : Gender and age distribution ofHSV conjunctivitis 
Range of age (years) 
0 to 20 21 to 40 41 to 60 61 to 80 
Gender Male 
Female 
4 
3.5 
3 
2.5 
No of 2 
cases 
1.5 
1 
0.5 
0 
3 
4 
0-20 21-40 41-60 61-80 
Age group 
1 
• male 
lil female 
Figure 4.7 : Gender and age distribution of HSV conj unctivitis 
0 
A female preponderance of I .5: 1 was noted in patients with HSV conjunctivitis over the 
age of20 but no difference was found in those under 20 years of age. 
55 
Table 4.8 ; Distribution of HSV conjunctivitis according to race 
Race 
Malay 
Chinese 
12 
10 
8 
No of 6 
cases 
4 
2 
No ofpatients (n=12) 
Malay 
11 
1 
Race 
Chinese 
Percentage (%) 
91.7 
8.3 
Figure 4.8 : Distribution ofHSV conjunctivitis according to race 
T he majority ofHSV conjunctivitis cases comprised of Malays (91.7 %) as for the racial 
distribution in Kelantan population was simi lar to the distribution seen in viral 
conjunctivitis. 
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4.4. HSV CONJUNCTIVITIS : CLINICAL FEATURES 
4.4.1. SOURCE OF INFECTION 
The source of infection in HSV and nonHSV conjuntivitis are listed in Table 4.9. 
Table 4.9 : Frequency of source of infection for HSV and NonHSV conjunctivitis 
HSV conjunctivitis NonHSV conjunctivitis 
n=12 n=58 
Source of infection No of patients(%) No of patients (%) 
Contact conjunctivitis 8 (66.7) 23 (39.7) 
URTI 0 (0.0) 2 (3.4) 
Unknown 4 (33.3) 25 (43.1) 
Others 0 (0.0) 8 (13.8) 
Contact conjunctivitis was the major source of infection for HSV conjunctivitis, 
accounting for 66.7 % ( 8 out of 12 cases). The remaining 4 (33.3%) patients had not 
been aware of contact with conjunctivitis, respiratory infection (UR TI ) or urogenital 
disease. In nonHSV conjunctivitis, the source of infection was not known in majority of 
cases (43.1%). This was followed by contact conjunctivitis (39.7%) and URTI 
(3.4%).0ther sources of infection (13.8%) were alleged ocular foreign body (5 cases), 
improper handling of contact lenses (2 cases) and blistering skin lesion ( 1 case). 
57 
Table 4.10 : Frequency of contact person for contact conjunctivitis in HSV and NonHSV 
conjunctivitis 
HSV conjunctivitis NonHSV conjunctivitis 
n=12 n=58 
Contact person No of patients (%) No of patients(%) 
Family member 7 (58.3) 16 (27.6) 
Friends 0 (0.0) 5 (8.6) 
Neighbour 0 (0.0) 1 (1.7) 
Others 1 (8.3) 1 (1.7) 
Out of 12 patients of HSV conjunctivitis, 7 (58.3%) had been in close contact with a 
family member suffering from conjunctivitis. One patient gave history of exposure to 
another patient having conjunctivitis. In nonHSV conjunctivitis, majority of cases (27%) 
had contracted the disease from family members whereas 5 cases (8.6%) from friends, 1 
case from a neighbour and another from a patient at a health center. 
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4.4.2. SYMPTOMS AND SIGNS 
The presenting symptoms and signs ofHSVand nonHSV conjunctivitis are listed in Table 
4.11 to Table 4.12. 
Table 4.11 : Presenting symptoms ofHSV and NonHSV conjunctivitis 
HSV conjunctivitis NonHSV conjunctivitis 
n=12 n=58 
Symptoms No of patients(%) No of patients(%) 
Laterality 
Unilateral 9 (75.0) 23 (39.7) 
Bilateral 3 (25.0) 35 (60.3) 
Foreign body sensation 12 (100.0) 57 (98.3) 
Lacrimation 12 (100.0) 57 (98.3) 
Eye discharge 9 (75.0) 40 (69.0) 
Itchiness 9 (75.0) 32 (55.2) 
Photophobia 7 (58.3) 35 (60.3) 
Blurred vision 6 (50.0) 29 (50.0) 
Foreign body sensation and lacrimation were the main symptoms that were present in 
both HSV and nonHSV conjunctivitis patients. The other common features found in both 
groups were presence of eye discharge, photophobia and blurring of vision. 
However, majority ofHSV conjunctivitis cases were unilateral (9 out of 12 cases; 75.0%) 
whereas majority of nonHSV conjunctivitis cases were bilateral (35 out of 58 cases; 
60.3%). 
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Table 4.12 : Presenting signs ofHSV and Non HSV conjunctivitis 
HSV conjunctivitis NonHSV conjunctivitis 
n=12 n=58 
Signs No of patients (%) No of patients (%) 
Conjunctival injection 
Mild 3 (25.0) 28 (48.3) 
Moderate 6 (50.0) 24 (41.4) 
Severe 3 (25.0) 6 (10.3) 
Conjunctival reaction 
Follicular 6 (50.0) 28 (48.3) 
Papillary 5 (41.7) 20 (34.5) 
Mixed 1 (8.3) 10 (17.2) 
Conjunctival haemorrhage 0 (0.0) 3 (5.2) 
Eye discharge (mucoid) 8 (66.7) 37 (63.8) 
Lid involvement 9 (75.0) 32(55.1) 
Swelling 9 (75.0) 30 (51.7) 
Blisters 0 (0.0) 2 (3.4) 
Corneal involvement 7(58.3) 31(53.4) 
Punctate keratitis 5 (41.7) 18(31.0) 
Dendritic keratitis 1 (8.3) 1(1. 7) 
Disciform keratitis 1 (8.3) 9 (15.5) 
Nummular keratitis 0 (0.0) 10 (17.2) 
Pseudomembrane 3 (25.0) 5 (8.6) 
Preauricular lympadenopathy 1 (8.3) 4 (6.9) 
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In both HSV conjunctivitis and nonHSV conjunctivitis, the conjunctival reaction was 
mainly of follicular response which was 50.0% (6 out of 12 cases) and 48.3% (28 out of 
58 cases), respectively. Mucoid eye discharge was also a common presentation in both 
the groups, comprising of 66.7% and 63.8%, accordingly. The other common feature 
noted in this study was the corneal involvement which occurred in 7 (58.3 %) out of 12 
patients with HSV conjunctivitis and 31 (53.4%) out of 58 patients of nonHSV 
conjunctivitis. In both the groups, the corneal involvement were mainly of punctate type. 
However, in nonHSV conjunctivitis, there were 7 patients presented with more than one 
type of keratitis. Preauricular lymphadenopathy was elicited in HSV as well as nonHSV 
conjunctivitis which accounted for 8.3% (1 of 12 cases) and 6.9% (4 of 58 cases), 
respectively. 
Regarding conjunctival injection, majority of HSV conjunctivitis patients presented with 
moderate conjunctivitis comprising of 50% (6 of 12) of cases whereas in nonHSV 
conjunctivitis, most of them presented as mild conjunctivitis accounting for 48.3~'0 (28 of 
58 cases). Lid involvement was seen more in HSV conjunctivitis than nonHSV 
conjunctivitis which was 75.0% and 55.4%, respectively. Nevertheless, no herpetic 
vesicles was seen in patients with HSV conjunctivitis. Thirty (51. 7%) cases of nonHSV 
conjunctivitis presented with lid swelling and 2 (3.4%) cases had blistering lesion over 
the eyelids which followed the dermatome of ophthalmic division of trigeminal nerve. 
Pseudomembrane formation was seen quite frequently in HSV conjunctivitis (25. 0% ). 
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5. DISCUSSION 
5. DISCUSSION 
Viral conjunctivitis is a common eye problem encountered not only in ophthalmology 
clinic but in outpatient clinic as well. Various viral aetiologies have been incriminated 
causing it, including adenovirus, vaccinia, herpes simplex virus and poxvirus, with 
adenovirus being the most prevalent causative agent. 
Herpes simplex virus (HSV) is rare cause of conjunctivitis alone without cornea or lid 
involvement. This is shown in a study by Uchio et al wherein the prevalence of HSV 
conjunctivitis is very low accounting for 4.3 % of cases (Uchio et al,2000). However, 
having said that, HSV conjunctivitis may involve into corneal involvement if not 
properly managed. In fact, HSV is the major cause of corneal blindness in developed 
countries (Darougar et al, 1985). 
Due to the serious morbidity of this infection, we planned to conduct a study to detect 
HSV infection in viral conjunctivitis and consequently, determine the prevalence rate of 
the infection in viral conjunctivitis cases in Hospital University Sains Malaysia. Apart 
from that, we would also like to identify the clinical features pertaining to HSV 
conjunctivitis which might help us in differentiating it from other causes of viral 
conjunctivitis and hence, assist us in diagnosing and managing these cases. 
In this study, the method used was polymerase chain reaction alone. Ideally, there should 
be a comparison with the present gold standard which is viral culture. There are few 
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reasons why this method had been choosen for this study. First and foremost, polymerase 
chain reaction is a more sensitive and specific method compared to viral culture method. 
This fact has been established in many studies conducted throughout the world. In a study 
by Kaye et al (2000), it was shown that the sensitivity and specificity ofPCR for HSV-1 
were 82% and 78% respectively whereas the sensitivity and specificity of culture were 
2% and 100% respectively. Using 2 different types of specimens, Hidalgo et al (1998) 
showed that nested PCR gave a higher positive rate of HSV than viral cultures, in 
corneal scrapings being 87.5% vs 31.25% and in tear film being 75% vs 12.5%. The high 
sensitivity and specificity of PCR in detecting HSV may help us to start antiviral 
treatment such as acyclovir earlier, and thus, may avoid possible serious complication 
such as keratitis which can lead to corneal perforation and blindness. 
The use of viral culture as a gold standard is not practical, particularly in this study. 
There are few reasons for this method to be inapplicable. Firstly, it was due to the budget 
constraint as this method is quite expensive. Secondly, even though viral culture remains 
the gold standard for definitive isolation and further characterization of the organism, the 
pitfalls of this method are numerous. Viral isolation requires viable organisms and hence, 
special transport media as well as prompt transport of specimens from patient to 
laboratory is necessary (Elnifro et al, 1999) and this is difficult to be applied in our clinic 
setup due to the lack of man power. Thirdly, it is time consuming, insensitive and 
subjective, along with requirement of highly technically trained personnel. 
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In our study, seventy cases of viral conjunctivitis were studied over a period of 1 year 
(November 2002 to November 2003). The samples were collected from patients attending 
ophthalmology and out patient clinics in Hospital Universiti Sains Malaysia. These cases 
presented to the clinic with either conjunctivitis alone, keratoconjunctivitis or 
blepharoconjunctivitis. It was shown that in our study, viral conjunctivitis occurred more 
in adult population (80%) whereby the highest proportion of cases seen between 21 to 40 
years age (45.7%). This result corresponds to a study done by Weiss et al (1993) showing 
that only 13 % of acute conjunctivitis in childhood were due to viral infection whereas up 
to 80% of cases were due to bacterial infection. However, Fitch et al (1989) reported that 
in adult the prevalence of viral and bacterial etiologies of acute conjunctivitis were 
almost equal, comprising of 36 % and 40 %, respectively. 
With respect to the gender distribution, this study showed a slight female preponderance 
(51.4% vs 48.4 %). In general, there is no sex predilection in viral conjunctivitis except 
in certain types of viral etiologies. Although, some studies have shown a slight male 
preponderance affecting people between ages 20 and 40 years old in adenoviral 
conjunctivitis and in recurrent herpetic ocular disease (Asbell et al, 1996; Hyndiuk & 
Glasser, 1996). 
In Kelantan, the male to female ratio is almost equal. However, in Kota Bharu district 
itself, in term of figures, the female population is slightly more compared to the male 
population (Housing census, 2000). Therefore, this may explain the slight female 
preponderance of viral conjunctivitis in HUSM found in this study. 
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The ethnic groups in Malaysia consist of three major races and they are Malay, Chinese 
and Indian. According to the population distribution and basic demographic 
characteristics, majority of the population in Kelantan belong to Malays (95.0 %), 
followed by Chinese (3.8%) and Indians (0.3%) (Housing Census 2000). In this study, 
majority of viral conjunctivitis patients presenting to the ophthalmology clinic, HUSM 
were Malays comprising of 95.7 %. Therefore, the result obtained actually reflects the 
racial distribution in the population. 
The prevalence rate of herpes simplex infection in viral conjunctivis in HUSM was 
17.1% ( 95% CI =8.1,26.0). However, this is not in accordance with previous reports in 
which the prevalence ofHSV ocular infection ranges froml.4 to 7% (Uchio et al, 2000; 
Harding et al,1987; Darougar et al, 1985;) The higher prevalence ofHSV conjunctivitis 
in our study might be due to few reasons. First, the prevalence in previous reports ofHSV 
conjunctivitis were referring only to cases with acute follicular conjunctivitis in the 
absence of corneal or lid signs whereas our study was referring to cases of HSV 
conjunctivitis which either presented with conjunctivitis alone, blepharoconjunctivitis or 
keratoconjunctivitis. Therefore, the pick-up rate of HSV infection was more compared to 
the reported studies. 
Furthermore, in our study, the method used in detecting the prevalence of herpes simplex 
ocular infection was by PCR method. PCR, a nucleic acid amplification procedure is very 
sensitive and highly specific compared to viral culture, proven by various studies (Kaye 
et al, 2000; Hidalgo et al, 1998; Kowalski et al, 1993). Owing to this, PCR is recognized 
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as a potential modem diagnostic tool for detection and identification of certain infectious 
agents such as adenovirus, HSV and C trachomatis. Jackson and coworkers (1996) had 
developed a multiplex PCR for simultaneous investigation of adenovirus and HSV in 
ocular swabs and reported that PCR had a considerable potential for the rapid diagnosis 
of viral eye disease particularly if P-globin primers can be included in the reaction. 
Another study by Yamamoto et al ( 1994 ), concluded that PCR can be a useful qiagnostic 
tool for confirming clinical observation in cases of herpetic keratitis. All in all, this may 
explain the high prevalence rate ofHSV infection in viral conjunctivitis in our study. 
In previous studies, the methods used in detecting the prevalence of herpes simplex 
ocular infections were by HSV isolation via viral culture method which, as mentioned, 
has a lower sensitivity rate. As a result, it may the cause of low prevalence in those 
studies. 
Another explanation that may contribute to the high prevalence rate of HSV 
conjunctivitis in this study is the fact it was a hospital based study as compared to other 
studies mentioned, which were epidemiological studies. The results found were actually 
comparable to one hospital based study done by Wishart et al ( 1994) showing that 21% 
of acute conjunctivitis cases found in ophthalmic casualty department were due to HSV 
infection. 
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In addition, the small sample size obtained may contribute to the high prevalence rate of 
HSV conjunctivitis in HUSM. As a result, it may give rise to a seemingly high 
epidemiological frequency. 
This study has shown that the age of the patients with HSV conjunctivitis ranged from 12 
to 68 years but the conjunctivitis is more commonly seen among adult age group (21 to 
40 years old) accounting for 58.3 % of cases, similar to age distribution in viral 
conjunctivitis ( 45.7% ). This result is slightly different from the study done by Uchio et al 
(2000) whereby most of the cases occurred in 50-59 year age group. It may be due to the 
age distribution in these two different places. Kelantan population has 41.5% of total 
population below 15 years of age whereas Japanese population has a larger size of older 
population. However, Uchio et a1 (2000) reported in his study that the age distribution of 
HSV conjunctivitis was similar to adenoviral conjunctivitis with 65°/o occurring in 20-59 
year age group. This is similar to our study where our age distribution of HSV 
conjunctivitis in HUSM occurring in 20-60 years old accounted for 75% (9 out of 12 
patients). 
In this study, it was impossible to determine whether the infection was primary or 
recurrent since we did not measure serum antibody level to HSV. However, it has been 
reported that the reliability of serological tests for the diagnosis of HSV infection is 
limited (Pramod et al, 1997; Field et al, 1993). It also has been reported by many workers 
from developed countries that circulating antibodies against HSV relatively remain 
constant, though fluctuations occur occasionally (Wilhelmus et al, 1986) 
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In previous studies, it has been reported that primary ocular HSV infection presents 
predominantly in two age groups consisting of children and young adult age group, with 
equal prevalence. However, Darougar et al (1985) reported in his case series, on 108 
patients with primary ocular HSV infection, the proportion of cases in adolescents and 
young adults has increased from 41 % to 64 % with mean age of 25 years. A study by 
Liesegang et al (1989) also suggested that primary herpes is now more frequent in adults 
than previously. This is further supported by a recent study done by Pramod et al (1997) 
showing that 50% of "first episode"of HSV keratitis were seen in adolescent and young 
adult whereas only 9.09% constituted children below 5 years of age. Thus, in our study, 
where the age ranged from 12 to 68 years (both primary as well as recurrent cases) were 
seen. As a consequence, we could not really differentiate the clinical features of HSV 
conjunctivitis between primary and recurrent ocular infection. 
Several studies had shown that there was no sex difference in primary HSV ocular 
infection (Darougar et al 1985; Uchio et a1,1993). However, in recurrent HSV ocular 
infection, studies by Wilhelmus et al (1981) and Wishart et al (1987) demonstrated that 
incidence was higher in male compared to female (aged over 25 and 15, respectively). No 
difference in terms of gender distribution was found in age less than stated. On the 
contrary, Uchio et al (1993) had found that the recurrence rate was higher in women aged 
50 years or younger than in women aged 51 years or older but in general, there was no 
sex difference in recurrent HSV ocular infection. 
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Our study has shown that there is female preponderance in cases of HSV conjunctivitis 
accounting for 58.3% females and 41.7% males but in tenn of cases, the distribution is 
almost equal where 7 cases are females and 5 cases were males. In addition, a female 
preponderance of 1.5:1 is noted in patients over the age of20 years old but no difference 
is found in those under 20 years of age. As this study consists of both primary and 
recurrent HSV ocular infections, the result obtained cannot be compared with other series 
and hence, sex difference cannot be elicited. However this is not significant considering 
sample size was very small and thus, not reflecting the true picture. 
Based on ethnic group, majority of HSV conjunctivitis cases in this study comprised of 
Malay, again reflecting the racial distribution in Kelantan population (Housing census, 
2000). Apart from that, there was no significance of this observation given the small 
number of cases involved. 
With regards to the source of infection in this study, the major source of infection for 
HSV conjunctivitis was contact conjunctivitis in which 7 had been in close contact with 
family members and one contracted it from other patients. This finding is similar to the 
pattern seen in the study of HSV conjunctivitis by Uchio et al (2000), the largest 
proportion of patients had been in close contact with a friend or colleague suffering from 
conjunctivitis. 
Humans are the sole natural hosts ofHSV. The virus can be transmitted by direct contact 
with infected cutaneous lesions, secretions of infected mucosa, salivary droplets from 
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children and adults with active disease (cold sores), and the saliva or fomites of 
asymptomatic, virus-shedding carriers (Nahmias et al, 1973). A study by Darougar et al, 
demonstrated that the source of infection identified in 24% of cases were contact with 
patients with an active skin HSV infection or patients having HSV lesions on their own 
lips, nose or face (Darougar et al, 1985). Spread via droplets is postulated, but not well 
documented (Verdier & Krachmer,1984). These various sources of infection could 
probably be elicited in our study with a larger sample size. 
Regarding the clinical presentation of HSV conjunctivitis in our study, the symptoms 
were mainly of eye irritation described as foreign body sensation and lacrimation, as well 
as mucoid eye discharge, followed by photophobia and blurred vision which were less 
frequent. Majority of HSV conjunctivitis patients showed moderate conjunctivitis which 
accounted for 50% of cases as compared to nonHSV conjunctivitis patients which 
showed mild conjunctivitis, comprising of 48.3% of cases. In both the groups, the 
conjunctival reaction seen was mainly of follicular type. This finding corresponds well to 
the fact that one of the main causes for follicular reaction is viral infection (Kanski, 
1999). 
As for keratitis associated with conjunctivitis in this study, generally the corneal 
involvement was seen equally and frequently in both the HSV and nonHSV 
conjunctivitis, which was 58.3% and 53.4%, accordingly. Subepithelial punctuate 
keratitis was found in both the HSV and nonHSV conjunctivitis (41% and 31%, 
respectively). Whereas dendritic keratitis was more frequently seen in HSV conjunctivitis 
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(8.3%) as compared to n~mular and disciform keratitis in nonHSV conjunctivitis 
(17.2% and 15.5%, respectively). The dendritic keratitis which was the least frequent 
keratitis seen in nonHSV conjunctivitis (1.7%) in this study, was most likely due to 
herpes zoster. 
Apart from that, it was noted in our study that all four cases ofHSV conjunctivitis treated 
by topical antibiotic with steroid showed corneal involvement (3 cases of punctate 
keratitis and a case of dendritic ulcer). Nevertheless, these findings could not really 
differentiate whether the corneal involvement was due to the treatment or they were just 
part of the natural course ofHSV ocular infection. 
Topical steroid can be associated with punctate keratitis which may be attributed to the 
preservatives, or the mechanical effects of aggregates of steroid particles in suspension 
producing a mechanical epithelial keratitis (Palmer J\.1L & Hyndiuk RA, 2000). The use 
of topical steroid has been associated with prolongation of infectious epithelial ulceration 
and with an increase in the size of these ulcers. Progression from dendritic to 
geographical ulceration and, probably, the risk of developing stromal inflammation later, 
are enhanced by the use of steroids, particularly when used during the stage of active 
viral replication in the epithelium (Hyndiuk & Glasser, 1996) 
Though, looking at our study the corneal involvement in HSV conjunctivitis occurred 
quite frequently (58.3%), we are still unable to say whether it is a part of the natural 
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course of disease or as a complication of steroid therapy as this was a cross-sectional 
study. 
Lid involvement was seen more frequently in HSV (75.0%) than nonHSV conjunctivitis 
(51.7%) in the form of lid swelling, whereas 2 patients (3.4%) had blisters on eyelids in 
nonHSV conjunctivitis. However, the vesicular blepharitis in these patients actually 
followed the dermatome of ophthalmic division of trigeminal nerve distribution which 
made the diagnosis of herpes zoster ophthalmicus the most probable one. In our study, 
pseudomembrane formation (25.0%) was seen more frequently than preauricular 
lymphadenopathy (8.3%) in HSV conjunctivitis. 
Herpes simplex virus should always be considered in the differential diagnosis of acute or 
subacute follicular conjunctivitis (Verdier et al, 1984). Acute follicular conjunctivitis in 
HSV ocular infection can occur in both primary and recurrent HSV ocular infection, with 
or without lid or corneal involvement (Wishart et al, 1987; Darougar et al, 1985). Parallel 
to these observations, most of the patients with HSV conjunctivitis in this study presented 
with acute follicular conjunctivitis. 
The clinical features seen in our study was similar to the ones seen in adenoviral 
conjunctivitis type 8 and 19 from group D subgenera which consisted of moderate to 
severe conjunctivitis with commonly subepithelial punctate lesion (Aoki et al, 1982). The 
degree of moderate to severe follicular conjunctivitis of HSV infection with less frequent 
preauricular lympadenopathy were also comparable to the study done by Uchio et al 
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(2000) but their study noted that early corneal lesions was less frequent..These mixed and 
dissimilar findings may pe due to the small sample size of our study in comparison with 
other published studies. 
In this study, it had shown that 75% of HSV conjunctivitis patients presented with 
unilateral involvement. This is consistent with several studies indicating that HSV ocular 
infection is unilateral in majority of cases ( about 80% to 90%) whereas bilateral disease 
is unusual and occurs in about 2% of patients in separate studies (Uchio et al, 2000; Bell 
et al,1982; Wilhelmus et al, 1981). Although the low occurrence of bilateral illness may 
help to discriminate HSV conjunctivitis from adenoviral conjunctivitis, it seems difficult 
to differentiate them clinically, especially in the early clinical stage. 
Currently diagnosis of infectious disease is carried out by routine microscopy, culture and 
serological methods, which takes around 1-3 days and even up to 2 weeks to a month. For 
serious life threatening and vision threatening, infections and pathogens that are difficult 
to culture, immediate diagnosis will have a great impact in appropriate treatment and 
proper clinical management. This is rightly so in cases of HSV ocular infections. In 
addition to the availability of treatment which are used not only to treat but preventing 
complications, the higher prevalence rate of HSV conjunctivitis in this study may warrant 
the need for diagnostic testing. 
In this genomic era with the availability of microbial genome sequences it is possible to 
carry out molecular DNA based diagnostic tests for almost all infections and this includes 
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HSV infections. Having said that, although this prevalence study was not validated by 
comparison against an established gold standard which is the viral culture but in ideal 
situation, the use ofPCR as a diagnostic test might be very useful. 
Polymerase chain reaction (PCR) has been a proven model for rapid diagnosis. Apart 
from having higher sensitivity compared to conventional methods, the other potential 
advantages are the same day diagnosis (2 to 4 hours result) as well as the same day 
identification of pathogen. Nonetheless, due to its sensitivity, false positive result may be 
found as a result of contamination of samples and this can be avoided by meticulous use 
of preventive measures. The specificity of primers is typically analyzed by evaluating the 
production of the target fragment in relation to other products by gel electrophoresis. In 
our study, we had used a commercially available primer kit which is Herpes Simplex 
Virus Type 1/2, DNA polymerase, Primer set kit (Cat. No.: SP-10319, Maxim Biotech. 
Inc.). 
Furthermore, nowadays, the PCR test is becoming less expensive than before. The 
expenditure of a laboratocy setup for PCR is actually more or less similar to other 
laboratory set up, particularly the viral laboratory, ranging around RM 300 000 to RM 
350 000 and thus, the application of PCR as a diagnostic test may actually be cost 
effective. 
Once again, owing to its high sensitivity and specificity as well as other promising 
advantages, the PCR may one day be the 'gold standard' of diagnostic test in replacement 
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of the conventional method, with special regard to viral isolation which obviously has a 
low sensitivity and lots of drawbacks. In fact, PCR amplification of HSV DNA in CSF 
specimens is now the recognized reference standard assay for the sensitive and specific 
diagnosis of central nervous system infections caused by HSV ( Tang YW et al, 1999). 
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6. CONCLUSION 
6. CONCLUSION 
HSV is the major cause of corneal blindness in developed countries. The documentation 
of clinical and virological features of this important ocular pathogen, however, is far 
inadequate in developing and under developed countries. Well documented clinical and 
virological features are a paramount importance in cases of HSV ocular diseases for 
planning ophthalmic services, estimating morbidity and social impact of this condition, 
investigating risk factors and developing strategies to control the disease. 
In comparison to other studies, our study showed higher prevalence rate of HSV 
conjunctivitis in HUSM . This could be due to the method used as well as the type of 
study carried out. In most studies, viral culture which is less sensitive was used whereas 
in this study, PCR method which has been shown to have a high sensitivity and 
specificity was utilized. Because of its exquisite sensitivity, false positive result may be 
encountered which could give rise to higher prevalence rate in this study but scrupulous 
technique was applied in this PCR study to prevent contamination of the samples and 
thus, avoiding false positive result. In addition, this study was a hospital based study as 
compared to other studies with lower prevalence rate of HSV conjunctivitis which were 
epidemiological based studies. 
One of the limitations in this study is a lack of comparison with other method such as 
viral culture which remains "the gold standard" at present. It could not be done in this 
study due to the time and budget constraints. In addition, viral culture needs a technically 
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trained personnel to ensure viral growth. On the whole, this could perhaps illustrates the 
superiority of PCR over viral culture. 
As for clinical features, unilaterality with presence of moderate follicular conjunctivitis 
are highly suggestive of HSV conjunctivitis and may help to distinguished it from 
adenoviral conjunctivitis. Even though certain results are comparable to other studies but 
their significance could not be elicited due to a small sample size. This problem is also 
applied in analyzing the demographic characteristics ofHSV conjunctivitis. 
The other limitations in analyzing the clinical features were the use of topical treatment, 
particularly, topical steroid which may alter the fmdings in patients with HSV 
conjunctivitis as well as nonHSV conjunctivitis. This problem was a little bit difficult to 
overcome since most of the patients in our study were patients whose conjunctivitis was 
not resolved with prior treatment either from local health clinics or general practitioner. 
Finally, we recommend further study with larger sample size needed to determine the true 
prevalence of HSV conjunctivitis and its clinical features as well as to identify the 
demographic pattern which may contribute as risk factors for HSV conjunctivitis. This 
study should be done with comparison with the current gold standard that is the viral 
culture and preferably, multi centered, especially if time is the major constraint in getting 
a larger sample size. Since our present study is cross-sectional, we could not really study 
the natural history of HSV ocular infection in our setup. Therefore, in addition to the 
Stt. on mentioned, this study should also be a prospective type as information sugge 
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regarding the natural course of the disease can then be obtained and hence developing 
strategies to bring the disease under control, along with preventing complications. 
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regarding the natural course of the disease can then be obtained and hence developing 
strategies to bring the disease under control, along with preventing complications. 
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8. APPENDICES 
APPENDIX 1 
OPTHALMOLOGY DEPARTMENT 
SCHOOL OF lviEDICINE 
UNIVERSITY SAINS MALAYSIA 
DATE: 
ANALYSIS OF VIRAL CONJUNCTIVITIS CASES TO DETERMINE 
THE PREVALENCE OF HSV CONJUNCTIVffiS USING PCR 
1. BIODATA 
INii 11111111111111111111111 
I RN I I I I I I I I I Age I I I years rn mths [I] Days 
'--1 S_ex _____ _..l F I M '--l R_a_ce_..L.......-...11 M- Malay 
C-Chinese 
I- Indian 
S-Siamese 
0- Others ; specify ____ _ 
2. CLINICAL PRESENTATION 
2.1 SOURCES OF INFECTION 
CONTACT FROM 
CASES PERSON PLACES 
Conjunctivitis Family Home 
URTI Friends Health centre 
Urogenital ds Coll~ague School 
Unknown Neighbour Swim.~ool 
*Others Unknown *Others 
* if others to specify *Others 
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2.2 SYMPTOMS AND SIGNS 
SYMPTOMS 
duration 
affected eye RE LE 
foreign body sensation 
lacrimation 
eye discharge 
itchiness 
photophobia 
blurred vision RE LE 
* others ( to specify ) 
SIGNS 
VISIOn RE LE 
conjunctival injection mild moderate severe 
conjunctival reaction follicular papillary mixed 
conjunctival haemorrhag~ 
Eye discharge mucoid Purulent 
* others ( to specify ) 
Involvement of other ocular structure : 
Eyelids RE LE 
Cornea RE LE 
Types : punctate keratitis 
Dendritic keratitis 
* others ( to specify ) 
Preauricular l~padenopathy yes no 
Pseudomembrane yes no 
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3. TREA Th1ENT 
Treatment Yes No 
Topical antibiotic Yes No 
Topical steroid Yes No 
4. LABORATORY RESULT 
I PCR for herpes simplex virus +ve -ve 
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APPENDIX2 
BORANG MAKLUMAT DAN KEIZINAN PESAKIT 
Kajian Prevalens untuk Mengesan Jangkitan Herpes Simplex Virus 
dalam Kes-kes Konjuktivitis Virus di HUSM dengan Menggunakan 
TeknikPCR 
Pengenalan 
Jikalau anda mengalami jangkitan mata (conjunctivitis), anda dijemput untuk menyertai 
satu kajian penyelidikan secara sukarela yang melibatkan kehadiran anda ke Klinik Mata 
HUSM, di mana pemeriksaan mata untuk menentukan samada jangkitan kuman tersebut 
adalah disebabkan oleh kuman virus atau tidak, dan seterusnya swab pada konjunktiva akan 
diambil untuk ujian PCR bagi mengesan virus Herpes simplex. 
Seramai 100 orang peserta akan menyertai kajian ini, di mana mereka akan dipilih dari 
Klinik Mata dan Klinik: pesakit luar, HUSM mengikut kelayakan penyertaan. 
Anda akan dikehendaki datang ke Klinik Mata HUSM sekali sahaja pada hari tersebut 
Sekiranya anda didapati mengalami jangkitan mata, rawatan yang sewajamya, dan jika 
perlu, temujanji susulan akan diberi. 
Tujuan Kajian 
Kajian ini adalah bertujuan untuk menentukan prevalens atau kadar kejadian jangkitan virus 
Herpes simplex dalam kes-kes jangkitan mata yang disebabkan oleh virus (konjunktivitis 
virus) 
Kelayakan Penyertaan 
Doktor yang bertanggungjawab dalam kajian ini telah membincangkan kelayakan untuk 
menyertai kajian ini dengan anda. Adalah penting anda berterus terang dengan doktor 
tersebut tentang sejarah kesihatan anda. Anda tidak seharusnya menyertai kajian ini 
sekiranya anda tidak memenuhi semua syarat kelayakan. 
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Prosedur-prosedur Kajian 
Pada lawatan anda ke klinik mata, pemeriksaan mata akan dijalankan dan swab konjunktiva 
akan diambil pada mata yang berkenaan. 
Pemeriksaan mata yang akan dijalankan termasuk: 
a) Pemeriksaan mata mengunakan slit-lamp biomkroskopi 
b) Pengambilan spesimen konjunktiva dengan menggunakan swab. 
Risiko 
• Ubat bius akan dititiskan mata yang berkenaan sebelum prosedur tersebut 
untuk mengurangkan rasa ketidakselesaan semasa ianya dijalankan. 
• Swab pada kelopak mata berkenaan samada kelopak mata atas atau bawah 
akan dilakukan dengan menggunakan putik kapas yang steril. 
• Spesimen yang d.iambil dengan menggunakan swab tersebut akan 
dihantarkan ke makmal untuk ujian PCR bagi mengesan jangkitan virus 
Herpes simplex. 
Prosedur - prosedur kajian ini tidak akan mendatangkan sebarang risiko atau mudarat 
kepada pesakit. 
Rawatan 
Sekiranya ujian PCR menunjukkan keputusan yang positif untuk virus Herpes Simplex, 
anda akan dipanggil semula untuk menerima rawatan antiviral menggunakan 'Ointment 
Acyclovir'. Rawatan susulan juga akan dilakukan ke atas anda. 
So alan 
Sekiranya anda mempunyai sebarang pertanyaan mengenai kajian ini sila hubungi Dr. 
Azma Azalina bt Ahmad Alwi di Klinik Mata HUSM (Tel: 09-7664370 ). 
Kerahsiaan 
Maklumat perubatan anda akan dirahsiakan oleh doktor dan kakitangan kajian dan tidak 
akan didedahkan secara umum melainkan jika ia dikehendaki oleh undang-undang. 
Tandatangan 
Untuk dimasukkan ke dalam kajian ini, anda atau wakil sah anda mesti menandatangani 
serta menarikhkan halaman tandatangan (lihat Lampiran 1) 
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Borang Maklumat dan Keizinan Pesakit 
Lampiran 1 
Halaman Tandatangan 
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat ini. 
Dengan menandatangani mukasurat ini, saya mengesabkan yang berikut: 
o Saya telah membaca semua maklumat dalam Borang Maklumat dan Keizinan 
Pesakit ini termasuk apa-apa maklumat berkaitan risiko yang ada dalam 
kajian dan saya telahpun diberi masa yang mencukupi untuk 
mempertimbangkan maklumat tersebut. 
o Semua soalan-soalan saya telah dijawab dengan memuaskan 
o Saya, secara sukarela, bersetuju menyertai kajian penyelidikan ini, mematuhi 
segala prosedur kajian dan memberi maklumat yang diperlukan kepada doktor, 
para jururawat dan juga kakitangan lain yang berkaitan apabila diminta. 
o Saya boleh menamatkan penyertaan saya dalam kajian ini pada bila-bila masa. 
o Saya telahpun menerima satu salinan Borang Maklumat dan Keizinan Pesakit 
untuk simpanan peribadi saya. 
Nama Pesakit (Ditera atau Ditaip) 
No. Kad Pengenalan Pesakit ( Baru ) 
Tandatangan I Cop jari Pesakit a tau Wakil Sah 
Nama Individu yang Mengendalikan Perbincangan 
Keizinan (Ditera a tau Ditaip) 
Tandatangan Individu Mengendalikan Perbincangan 
Keizinan 
Nama Saksi dan Tanda Tangan 
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Nama Singkatan dan 
Nombor Pesakit 
No. KIP (lama) 
Tarikh (ddMMyy) 
Tarikh (ddl\IMyy) 
Tarikh (ddl\IMyy) 
I 
APPENDIX3 
FLOWCHART 
Patient with conjunctivitis 
referred from outpatient clinic 
Patient with conjunctivitis 
attending ophthalmology 
clinic 
All conjunctivitis cases seen 
in ophthalmology clinic 
n=lOO 
History and clinical examination 
by primary investigator 
Clinically diagnosed viral 
conjunctivitis fulfilling selection 
criteria 
n=70 
Clinical features of viral 
conjunctivitis identified & 
documented 
Specimen obtained using 
sterile conjunctival swabs 
Detection ofHSV by PCR 
method 
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Clinically diagnosed non-viral 
conjunctivitis or viral 
conjunctivitis not fulfilling 
selection criteria 
n=30 
,, 
Excluded from study 
APPENDIX4 
age sex m race ctcases ctperson lateral 
1 50.00 female B 090752 malay none none unilateral 
2 40.00 female 8176330 malay cojunctiv family unilateral 
3 44.42 male 8203500 malay none none unilateral 
4 68.00 female B 179777 malay cojunctiv others unilateral 
5 36.00 female 8202511 malay cojunctiv family unilateral 
6 34.00 male A840791 malay cojunctiv family unilateral 
7 35.00 male 8188234 malay cojunctiv family unilateral 
8 36.00 female A078034 malay cojunctiv family bilateral 
9 21.42 male 8200112 chinese none none unilateral 
10 25.00 female 8155637 malay none none bilateral 
11 12.00 male 8209726 malay cojunctiv family unilateral 
12 20.00 female 8151109 malay cojunctiv family bilateral 
13 42.00 female 8069399 malay cojunctiv family bilateral 
14 34.00 male 8200561 malay none none bilateral 
15 33.00 male 8202208 malay none none unilateral 
16 55.00 male 8206332 malay others none unilateral 
17 58.00 male A013481 malay none none unilateral 
18 27.00 female A048236 malay cojunctiv neighbo unilateral 
19 40.00 male 8206322 malay none none unilateral 
20 16.00 female A 147498 malay none none unilateral 
21 54.08 male 8200412 malay others none unilateral 
22 36.00 male 8108150 malay cojunctiv friend unilateral 
23 37.00 female A930879 malay cojunctiv family unilateral 
24 31.00 male 8 064291 malay none none unilateral 
25 32.00 female A143752 malay others none unilateral 
26 11.00 male 8206822 malay none none unilateral 
27 52.00 male 8 207460 malay none none bilateral 
28 17.00 male 8 175739 malay none none bilateral 
29 22.00 male A840276 malay none none bilateral 
30 35.00 female A158742 malay cojunctiv family bilateral 
31 35.00 male A018849 malay cojunctiv friend bilateral 
32 65.00 female A005471 malay cojunctiv family bilateral 
33 16.00 female 8154054 malay none none unilateral 
34 7.00 male 8201011 malay cojunctiv family bilateral 
35 61.16 male 8200057 malay none none unilateral 
36 72.00 male 8204924 malay none none unilateral 
37 47.00 female 8101920 malay URTI family unilateral 
38 14.00 female A849622 malay others none bilateral 
05/22/0410:33:03 91 1/10 
APPENDIX4 
fbs lacrimal eyedc icth photo ph blur c.inflm 
1 yes yes yes no yes yes mild 
2 yes yes no yes yes no moderat 
3 yes yes no yes yes yes severe 
4 yes yes no no no no mild 
5 yes yes yes yes no yes moderat 
6 yes yes yes no yes yes mode rat 
7 yes . yes yes yes yes yes mode rat 
8 yes yes yes yes yes yes severe 
9 yes yes yes yes yes no mild 
10 yes yes yes yes no no mode rat 
11 yes yes yes yes no no mode rat 
12 yes yes yes yes no no severe 
13 yes yes yes yes yes yes mild 
14 yes yes yes yes yes yes mild 
15 yes yes yes yes yes yes mild 
16 yes yes no yes yes yes mild 
17 yes yes no yes yes yes mild 
18 yes yes yes yes yes yes mild 
19 yes yes no no yes yes mild 
20 yes yes no yes yes yes mild 
21 yes yes no no yes yes mild 
22 yes yes yes yes yes yes mild 
23 yes yes no no yes yes mild 
24 yes yes no no yes yes mild 
25 yes yes no no yes yes mode rat 
26 yes yes no yes yes yes mode rat 
27 yes yes no no yes yes mild 
28 yes no no yes no no mild 
29 yes yes no no no no mild 
30 yes yes yes yes yes yes mild 
31 yes yes no no no no mode rat 
32 yes yes no yes no no moderat 
33 yes yes no no yes no mode rat 
34 yes yes yes yes yes yes mild 
35 yes yes no yes yes yes mild 
36 yes yes yes yes yes yes mild 
37 yes yes yes no yes yes mild 
38 no yes yes no no yes mild 
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c.rxn c.hrg discharg eyelid cornea punctate dendrite 
1 follicular no absent normal yes no no 
2 papillary no absent swollen yes yes no 
3 papillary no absent swollen yes yes no 
4 follicular no absent normal no no no 
5 follicular no mucoid swollen yes yes no 
6 papillary no mucoid swollen yes yes no 
7 follicular no mucoid swollen yes no yes 
8 papillary no mucoid swollen yes yes no 
9 mixed no mucoid normal no no no 
10 papillary no mucoid swollen no no no 
11 follicular no mucoid swollen no no no 
12 follicular no mucoid swollen no no no 
13 follicular no absent normal yes yes no 
14 papillary no absent normal yes yes no 
15 papillary no absent normal yes no no 
16 papillary no absent normal yes yes no 
17 papillary no absent normal yes yes no 
18 follicular no absent normal yes no no 
19 papillary no absent normal yes yes no 
20 mixed no absent normal yes no no 
21 follicular no absent normal yes no no 
22 follicular no absent normal yes yes no 
23 papillary no absent normal yes no no 
24 follicular no absent swollen yes no yes 
25 follicular no absent swollen yes yes no 
26 papillary no absent swollen yes no no 
27 follicular no absent normal yes no no 
28 follicular no absent normal no no no 
29 follicular no absent normal no no no 
30 mixed no absent swollen no no no 
31 follicular no absent swollen no no no 
32 papillary no absent normal no no no 
33 papillary no absent swollen no no no 
34 follicular no mucoid normal yes yes no 
35 papillary no mucoid normal yes no no 
36 follicular no mucoid normal yes no no 
37 follicular no mucoid normal yes no no 
38 papillary no mucoid swollen yes yes no 
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disci nummular pseudomm lymphade treat ab steroid 
1 yes no no no no no no 
2 no no yes yes yes no no 
3 no no no no yes yes no 
4 no no no no no no no 
5 no no no no yes yes no 
6 no no yes no yes no no 
7 no no no no yes no no 
8 no no yes no yes no no 
9 no no no no no no no 
10 no no no no no no no 
11 no no no no yes yes no 
12 no no no no yes yes no 
13 yes no no no yes yes no 
14 no yes no no yes yes no 
15 yes no no no no no no 
16 no yes no no no no no 
17 no no no no no no no 
18 yes no no no no no no 
19 yes no no no no no no 
20 no yes no no no no no 
21 yes no no no yes yes no 
22 no yes no no yes yes no 
23 yes yes no no yes no no 
24 no no no no yes no no 
25 no no no yes no no no 
26 yes no no no no no no 
27 yes no no no no no no 
28 no no no no no no no 
29 no no no no no no no 
30 no no no no yes yes no 
31 no no no no yes yes no 
32 no no no no no no no 
33 no no no no no no no 
34 no no no no yes no no 
35 no yes yes no yes yes no 
36 no yes no no yes yes no 
37 no yes no no yes yes no 
38 no no no no yes yes no 
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both per 
1 . no positive 
2 yes positive 
3 no positive 
4 no positive 
5 no positive 
6 yes positive 
7 yes positive 
8 yes positive 
9 no positive 
10 no positive 
11 no positive 
12 no positive 
13 no negative 
14 no negative 
15 no negative 
16 no negative 
17 no negative 
18 no negative 
19 no negative 
20 no negative 
21 no negative 
22 no negative 
23 yes negative 
24 yes negative 
25 no negative 
26 no negative 
27 no negative 
28 no negative 
29 no negative 
30 no negative 
31 no negative 
32 no negative 
33 no negative 
34 yes negative 
35 no negative 
36 no negative 
37 no negative 
38 no negative 
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APPENDIX4 
age sex m race ctcases ctperson lateral 
39 9.00 male 8205825 malay cojunctiv family bilateral 
40 72.00 male A171960 malay none none bilateral 
41 32.00 female A126642 malay cojunctiv family bilateral 
42 25.83 female 8206345 malay others none unilateral 
43 12.00 female A907430 malay URTI family unilateral 
44 39.00 female A855257 malay others none bilateral 
45 33.00 male 8169022 malay cojunctiv family bilateral 
46 50.00 female 8186489 malay none none unilateral 
47 26.00 female A349203 malay cojunctiv family bilateral 
48 37.00 female A167032 malay cojunctiv friend bilateral 
49 53.00 female 8197457 malay cojunctiv family bilateral 
50 11.00 male 8046808 malay others neighbo bilateral 
51 41.33 male 8182962 malay others none bilateral 
52 39.00 female A081760 malay none none unilateral 
53 79.00 male A121784 malay none none bilateral 
54 12.00 female A153640 malay cojunctiv friend bilateral 
55 28.00 female A191922 malay cojunctiv family bilateral 
56 40.00 male 8226258 malay cojunctiv family bilateral 
57 31.00 female A 074531 malay cojunctiv family bilateral 
58 34.00 female A 112632 malay cojunctiv others bilateral 
59 31.00 male A 166380 malay cojunctiv family bilateral 
60 38.00 female A073735 others none none bilateral 
61 14.00 , male 8007789 malay none none bilateral 
62 14.00 female 8 209789 malay none none unilateral 
63 45.00 male A000020 malay none none bilateral 
64 32.00 female 8108298 malay cojunctiv friend bilateral 
65 49.00 female A840542 malay cojunctiv family bilateral 
66 44.67 male 8160214 malay none none bilateral 
67 78.00 female A872201 malay none none unilateral 
68 41.00 male A163390 malay none none unilateral 
69 41.00 male A 000569 malay cojunctiv family bilateral 
70 62.00 female A930270 chinese none none bilateral 
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fbs lacrimal eyedc icth photoph blur c.inflm 
39 yes yes yes no yes no mild 
40 yes yes yes yes yes yes mild 
41 yes yes yes yes no no mode rat 
42 yes yes no no yes no mode rat 
43 yes yes yes yes yes yes mode rat 
44 yes yes yes yes yes yes moderat 
45 yes yes yes no yes yes mode rat 
46 yes yes yes no yes yes severe 
47 yes yes yes yes yes yes severe 
48 yes yes yes no yes yes severe 
49 yes yes yes yes yes yes severe 
50 yes yes yes yes no no mild 
51 yes yes yes no no no mild 
52 yes yes yes no no no mild 
53 yes yes yes no no no mild 
54 yes yes yes yes no no mild 
55 yes yes yes yes no no moderat 
56 yes yes yes yes no no moderat 
57 yes yes yes yes no no moderat 
58 yes yes yes no no no moderat 
59 yes yes yes yes yes no moderat 
60 yes yes yes yes no no mode rat 
61 yes yes yes yes no no moderat 
62 yes yes no no yes no moderat 
63 yes yes yes yes no no moderat 
64 yes yes yes no no no mode rat 
65 yes yes yes yes no no mode rat 
66 yes yes yes no no no moderat 
67 yes yes yes no no no moderat 
68 yes yes yes no no no mode rat 
69 yes yes yes no yes no severe 
70 yes yes yes yes yes no severe 
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c.rxn c.hrg discharg eyelid cornea punctate dendrite 
39 follicular no mucoid swollen yes yes no· 
40 papillary no mucoid normal yes yes no 
41 follicular no mucoid normal yes yes no 
42 mixed no mucoid swollen yes no no 
43 mixed no mucoid swollen yes no no 
44 mixed no mucoid swollen yes yes no 
45 papillary no mucoid swollen yes yes no 
46 mixed yes mucoid swollen yes yes no 
47 follicular yes mucoid swollen yes yes no 
48 follicular no mucoid swollen yes yes no 
49 follicular no mucoid swollen yes yes no 
50 papillary no mucoid blisters no no no 
51 follicular no mucoid normal no no no 
52 papillary no mucoid swollen no no no 
53 follicular no mucoid normal no no no 
54 follicular no mucoid swollen no no no 
55 follicular no mucoid swollen no no no 
56 mixed no mucoid swollen no no no 
57 mixed no mucoid swollen no no no 
58 mixed no mucoid swollen no no no 
59 follicular no mucoid swollen no no no 
60 follicular no mucoid swollen no no no 
61 papillary no mucoid normal no no no 
62 follicular no mucoid blisters no no no 
63 papillary no mucoid normal no no no 
64 follicular no mucoid swollen no no no 
65 follicular no mucoid swollen no no no 
66 mixed no mucoid swollen no no no 
67 papillary no mucoid normal no no no 
68 papillary no mucoid swollen no no no 
69 follicular yes mucoid swollen no no no 
70 papillary no mucoid swollen no no no 
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disci nummular pseudomm lymph a de treat ab steroid 
39 no no no yes yes yes no 
40 no no no no yes no no 
41 no no yes no yes yes no 
42 no yes no no no no no 
43 no yes no no no no no 
44 no no no no yes yes no 
45 yes no no no yes no no 
46 no no no no yes yes no 
47 no no yes no yes no no 
48 no no yes no yes yes no 
49 no no no no yes yes no 
50 no no no yes no no no 
51 no no no no no no no 
52 no no no no no no no 
53 no no no no no no no 
54 no no no no yes yes no 
55 no no no no no no no 
56 no no no no yes yes no 
57 no no no no yes yes no 
58 no no no no yes yes no 
59 no no no no yes yes no 
60 no no no no no no no 
61 no no no no no no no 
62 no no no yes no no no 
63 no no no no yes yes no 
64 no no no no yes yes no 
65 no no no no yes yes no 
66 no no no no yes yes no 
67 no no no no yes no no 
68 no no no no yes no no 
69 no no no no yes no no 
70 no no yes no yes yes no 
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both per 
39 no negative 
40 yes negative 
41 no negative 
42 no negative 
43 no negative 
44 no negative 
45 yes negative 
46 no negative 
47 yes negative 
48 no negative 
49 no negative 
50 no negative 
51 no negative 
52 no negative 
53 no negative 
54 no negative· 
55 no negative 
56 no negative 
57 no negative 
58 no negative 
59 no negative 
60 no negative 
61 no negative 
62 no negative 
63 no negative 
64 no negative 
65 no negative 
66 no negative 
67 yes n~gative 
68 yes negative 
69 yes negative 
70 no negative 
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